Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline.
Open accessAbstract
OBJECTIVE: We developed clinical practice guidelines for congenital adrenal hyperplasia (CAH). PARTICIPANTS: The Task Force included a chair, selected by The Endocrine Society Clinical Guidelines Subcommittee (CGS), ten additional clinicians experienced in treating CAH, a methodologist, and a medical writer. Additional experts were also consulted. The authors received no corporate funding or remuneration. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions. The guidelines were reviewed and approved sequentially by The Endocrine Society's CGS and Clinical Affairs Core Committee, members responding to a web posting, and The Endocrine Society Council. At each stage, the Task Force incorporated changes in response to written comments. CONCLUSIONS: We recommend universal newborn screening for severe steroid 21-hydroxylase deficiency followed by confirmatory tests. We recommend that prenatal treatment of CAH continue to be regarded as experimental. The diagnosis rests on clinical and hormonal data; genotyping is reserved for equivocal cases and genetic counseling. Glucocorticoid dosage should be minimized to avoid iatrogenic Cushing's syndrome. Mineralocorticoids and, in infants, supplemental sodium are recommended in classic CAH patients. We recommend against the routine use of experimental therapies to promote growth and delay puberty; we suggest patients avoid adrenalectomy. Surgical guidelines emphasize early single-stage genital repair for severely virilized girls, performed by experienced surgeons. Clinicians should consider patients' quality of life, consulting mental health professionals as appropriate. At the transition to adulthood, we recommend monitoring for potential complications of CAH. Finally, we recommend judicious use of medication during pregnancy and in symptomatic patients with nonclassic CAH.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 331 cited sources checked · 0 supported · 0 flagged
- Findingcitation
Retrospective analysis of sudden infant death in the Czech Republic and Austria identified three genotype-proven cases of classic congenital adrenal hyperplasia among 242 samples screened.
“Indeed, retrospective analysis of sudden infant death in the Czech Republic and Austria identified three genotype-proven cases of classic CAH among 242 samples screened (23).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Females outnumber males in some but not all retrospective studies in which congenital adrenal hyperplasia was diagnosed clinically.
“In fact, females outnumber males in some (1,24,25) but not all (26) retrospective studies in which CAH was diagnosed clinically.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [1]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [26]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Screening markedly reduces the time to diagnosis of infants with congenital adrenal hyperplasia.
“Screening markedly reduces the time to diagnosis of infants with CAH (19 -22).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [19]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [20]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [21]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [22]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
The delay before correct sex assignment of severely virilized females is markedly reduced by screening.
“Although salt-wasting males would seem to derive the greatest benefit from screening programs, the delay before correct sex assignment of severely virilized females is also markedly reduced (22,31).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [22]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
In The Netherlands and Switzerland, adopting gestational age criteria improved the positive predictive value of screening.
“Indeed, in The Netherlands and Switzerland, adopting gestational age criteria improved the positive predictive value of screening (29,39).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [29]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [39]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Salt-wasting congenital adrenal hyperplasia patients ascertained through screening programs are equally likely to be male.
“In contrast, saltwasting CAH patients ascertained through screening programs are equally likely to be male (19,20,22).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [19]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [20]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [22]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
In Utah, the positive predictive value improved from 0.4 to 9.3% using similar methodology.
“In Utah, the positive predictive value improved from 0.4 to 9.3% using similar methodology (45).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Fetal sex determination from fetal Y-chromosomal DNA in maternal blood has been used in conjunction with prenatal treatment of congenital adrenal hyperplasia.
“Fetal sex determination from fetal Y-chromosomal DNA in maternal blood (65,66) has been used in conjunction with prenatal treatment of CAH (67,68).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [65]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [66]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [67]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [68]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
A modified LC-MS/MS protocol using a ratio of the sum of 17-hydroxyprogesterone and 21-deoxycortisol levels divided by the cortisol level had a positive predictive value of 100% when this ratio exceeded 0.53 in 1609 samples with a positive primary screen (of 242,500 samples screened by a German program) tested prospectively.
“A modified LC-MS/MS protocol using a ratio of the sum of 17-OHP and 21-deoxycortisol levels, divided by the cortisol level, had a positive predictive value of 100% when this ratio exceeded 0.53 when 1609 samples with a positive primary screen (of 242,500 samples screened by a German program) were tested prospectively (46).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Affected infants ascertained through screening have less severe hyponatremia (mean serum sodium at diagnosis of 134 mM with screening, 124 mM without).
“Affected infants ascertained through screening have less severe hyponatremia (mean serum sodium at diagnosis of 134 mM with screening, 124 mM without) (22,29).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [22]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [29]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Implementation of LC-MS/MS improved the positive predictive value of congenital adrenal hyperplasia screening in Minnesota from 0.8 to 7.6% during a 3-year follow-up period.
“Implementation of this approach improved the positive predictive value of CAH screening in Minnesota from 0.8 to 7.6% during a 3-yr follow-up period (44).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
High doses of maternally administered dexamethasone disrupted development of hippocampal neurons in late-term fetal rhesus monkeys.
“High doses of maternally administered dexamethasone also disrupted development of hippocampal neurons in late-term fetal rhesus monkeys (101).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [101]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Other uncontrolled reports document Cushingoid effects in small numbers of treated women.
“Other uncontrolled reports document Cushingoid effects in small numbers of treated women (73).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [73]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
A case-control study of 662 infants with orofacial clefts and 734 controls found higher incidences of isolated cleft lip (odds ratio 4.3) or cleft palate (odds ratio 5.3) among mothers who used glucocorticoids during the 4-month periconceptual period.
“A case-control study of 662 infants with orofacial clefts and 734 controls found higher incidences of isolated cleft lip ( odds ratio 4.3) or cleft palate (odds ratio 5.3) among mothers who used GCs “during the 4-month periconceptual period” (82).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [82]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Betamethasone treatment in mid to late gestation reduced brain weight and neuronal myelinization in fetal sheep.
“Betamethasone treatment in mid to late gestation reduced brain weight (98,99) and neuronal myelinization (100) in fetal sheep.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [98]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [99]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [100]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
A child born with complete generalized glucocorticoid resistance had no major organ defects.
“A child born with complete generalized GC resistance had no major organ defects (94).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Dexamethasone administered to pregnant sheep during early gestation in doses similar to those used in CAH prenatal therapy altered fetal adrenal and placental steroidogenesis.
“Dexamethasone administered to pregnant sheep during early gestation in doses similar to those used in CAH prenatal therapy altered fetal adrenal and placental steroidogenesis (97).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [97]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
A multicenter case-control study by the same group surveying glucocorticoid exposure among 1141 cases of cleft lip (with or without cleft palate), 628 with cleft palate, and 4143 controls found a lower risk (odds ratio = 1.7; 95% confidence interval = 1.1-2.6).
“A multicenter case control study by the same group surveying GC exposure among 1141 cases of cleft lip (with or without cleft palate), 628 with cleft palate, and 4143 controls found a lower risk (odds ratio ϭ 1.7; 95% confidence interval ϭ 1.1-2.6).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Questionnaires administered to dexamethasone-treated children showed more shyness and inhibition.
“Questionnaires administered to dexamethasone-treated children showed more shyness and inhibition (102).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Among 24 female fetuses where treatment was begun after week 9, the genitalia averaged a Prader score of 3.0.
“Among 24 female fetuses where treatment was begun after wk 9, the genitalia averaged a Prader score of 3.0.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Only a single small study indicates a modest but measurable effect of dexamethasone on postnatal cognitive function.
“and only a single small study indicates a modest but measurable effect of dexamethasone on postnatal cognitive function ( 104).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [104]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Exercise and psychological stresses such as anxiety and examinations do not require increased glucocorticoid dosing.
“Exercise and psychological stresses (e.g.anxiety and examinations) (134) do not require increased GC dosing (135).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [134]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [135]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
When glucocorticoid doses exceed 20 mg/m2 per day in infants and 15-17 mg/m2 per day in adolescents, there is loss of height SD score and shorter adult height SD score.
“When doses exceed 20 mg/m 2 ⅐ d in infants and 15-17 mg/m 2 ⅐ d in adolescents, there is loss of height SD score (SDS) and shorter adult height SDS (123-127).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [123]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [124]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [125]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [126]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [127]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
A high prevalence of benign adrenal masses has been observed by computed tomography imaging in adults with CAH, especially among those on inadequate glucocorticoid therapy.
“A high prevalence of benign adrenal masses has been observed by computed tomography imaging in adults with CAH, especially among those on inadequate GC therapy (150).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [150]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Irregular menstrual cycles are common in females with inadequately treated classic CAH.
“Irregular menstrual cycles are common in females with inadequately treated classic CAH (158, 159).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [158]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [159]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
The aldosterone to PRA ratio decreases with increasing phenotypic severity, demonstrating a spectrum of salt loss in the various forms of 21-hydroxylase deficiency.
“The latter decreases with increasing phenotypic severity, clearly demonstrating a spectrum of salt loss in the various forms of 21hydroxylase deficiency (112).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
A questionnaire study of 174 children prenatally treated and 313 untreated control children found no differences between treated and untreated groups with respect to nine social/developmental scales.
“A questionnaire study of 174 children prenatally treated and 313 untreated control children found no differences between treated and untreated groups with respect to nine social/developmental scales (103).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
In a controlled study of 62 adult women with CAH, there was no difference in the prevalence of irregular menses between treated CAH and control women.
“However, in a controlled study of 62 adult women with CAH (160), there was no difference in the prevalence of irregular menses between treated CAH and control women.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
In CAH children and adolescents on standard glucocorticoid therapy (10-20 mg/m2), there is no evidence of decreased bone mineral density assessed by dual-energy x-ray absorptiometry and normalized for height, irrespective of duration of treatment, type of glucocorticoid used, and 17-OHP or androgen levels.
“However, in CAH children and adolescents on standard GC therapy (10 -20 mg/m 2 ), there is no evidence of decreased BMD assessed by dual-energy x-ray absorptiometry and normalized for height, irrespective of duration of treatment, type of GC used, and 17-OHP or androgen levels (144 -147).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [144]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [145]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [146]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [147]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Systematic review and meta-analysis of these publications have not detected significant differences in behavior or temperament.
“Systematic review and metaanalysis of these publications have not detected significant differences in behavior or temperament (70),”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Adult height of patients treated with the combined growth hormone and GnRH agonist regimen for approximately 4 years was greater than the adult height of matched historical CAH controls treated with conventional therapy alone (SD −0.4 vs. −1.4, P=0.01).
“Adult height of the patients treated with this combined regimen for approximately 4 yr was greater than the adult height of matched historical CAH controls treated with conventional therapy alone (SD Ϫ0.4 vs. Ϫ1.4,P ϭ 0.01).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [200]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Menstrual irregularity is typically one of the presenting signs in NCCAH.
“Menstrual irregularity is typically one of the presenting signs (161, 162) in NCCAH.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [161]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [162]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Retrospective studies show that adult height is relatively independent of adrenal androgen levels in treated patients.
“Retrospective studies show that adult height is relatively independent of adrenal androgen levels in treated patients (186 -188).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [186]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [187]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [188]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Children with CAH have a higher body mass index than controls due to increased fat mass.
“Children with CAH have a higher body mass index than do controls due to increased fat mass (170).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [170]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
The pubertal growth spurt is attenuated in CAH adolescents.
“The pubertal growth spurt is attenuated in CAH adolescents (118).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
In a 2-year randomized parallel study of 28 children, patients receiving the experimental four-drug regimen had normal linear growth and bone maturation, despite elevated adrenal androgens.
“In a 2-yr randomized parallel study of 28 children, patients receiving the experimental four-drug regimen had normal linear growth and bone maturation, despite elevated adrenal androgens (198).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [198]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
There is limited evidence that initiation of glucocorticoid treatment before puberty might improve adult height in patients with NCCAH.
“However, there is limited evidence that initiation of GC treatment before puberty might improve adult height (187,196).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [187]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [196]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Subgroup analysis revealed that the addition of mineralocorticoid treatment was associated with increased height outcome.
“Subgroup analysis revealed that the addition of MC treatment was associated with increased height outcome.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [131]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Height approximating target height has been reported in patients with strict adherence to thrice-daily medication and monitoring every 3 months.
“Despite these concerns, height approximating target height has been reported in patients with strict adherence to thrice-daily medication and monitoring every 3 months (118,194,195).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [118]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [194]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [195]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Studies in a limited number of adolescent CAH patients showed a prevalence of polycystic ovaries on ultrasound corresponding to that in the general population.
“Studies in a limited number of adolescent CAH patients showed a prevalence of polycystic ovaries on US corresponding to that in the general population (165,166).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [165]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [166]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Oral glucose tolerance was normal in nine of 10 girls with classic CAH aged 8-20 years.
“Oral glucose tolerance was normal in nine of 10 girls with classic CAH aged 8 -20 yr (165).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [165]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
A four-drug regimen of flutamide, testolactone, reduced hydrocortisone, and fludrocortisone decreased growth rate, weight velocity, and bone maturation compared with conventional treatment with hydrocortisone and fludrocortisone in a crossover study of 12 children.
“A four-drug regimen of the antiandrogen flutamide, the aromatase inhibitor testolactone, reduced HC (8 mg/ m 2 ⅐ d), and fludrocortisone decreased growth rate, weight velocity, and bone maturation as compared with conventional treatment with HC and fludrocortisone in a crossover study of 12 children (197).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [197]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
The majority of women with CAH surveyed favored genital surgery before adolescence.
“The majority of women with CAH surveyed favored genital surgery before adolescence (184, 185).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [184]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [185]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
The pooled data from the systematic review and meta-analysis indicated a corrected adult height SD score of −1.05 in patients with classic CAH diagnosed before age 5 years.
“The pooled data indicated a corrected adult height SDS of Ϫ1.05.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [131]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
A 1- to 2-year nonrandomized study of children with CAH showed improved growth rate and height z score for bone age for growth hormone used alone (n=12) or in combination with GnRH agonist (n=8; P<0.0001).
“A 1-to 2-yr nonrandomized study of children with CAH showed improved growth rate and height z score for bone age for GH used alone (n ϭ 12) or in combination with GnRH agonist (GnRHa) (n ϭ 8; P Ͻ 0.0001) (199).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [199]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
If one examines unselected populations of hyperandrogenic, hirsute women, or patients in fertility clinics, the incidence of NCCAH is 2-4%.
“If one examines unselected populations of hyperandrogenic, hirsute women, or patients in fertility clinics, the incidence of NCCAH is 2-4% (167-169).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [167]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [168]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [169]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Eight patients had elevated steroid precursors postoperatively while on reduced hydrocortisone dose, presumably from adrenal rest tissue activation, which required increased hydrocortisone doses.
“Eight patients had elevated steroid precursors postoperatively while on reduced HC dose, presumably from adrenal rest tissue activation, which required increased HC doses.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [202]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Glucocorticoid doses were lower after than before adrenalectomy.
“However, GC doses were lower after than before adrenalectomy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [202]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingnone given
There are no published randomized and controlled trials of various treatments for NCCAH.
“There are no published randomized and controlled trials of various treatments for NCCAH.”
Quote in the paperSubstantial claim - Findingcitation
Reports studying adolescents and young adults differ concerning normal vs. reduced BMD.
“Reports studying adolescents and young adults differ concerning normal vs. reduced BMD (227).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [227]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Two adult female patients with salt-wasting CAH underwent adrenalectomy for infertility and became pregnant within 2 years.
“Two patients underwent adrenalectomy for infertility and became pregnant within 2 yr.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [203]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Longterm observational studies have been somewhat informative.
“Longterm observational studies have been somewhat informative (227,228,230,231).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [227]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [228]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [230]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [231]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Conflicting reports concern BMD and risk of fractures.
“Conflicting reports concern BMD and risk of fractures.”
Quote in the paperNot a substantial claim - Findingcitation
GnRH agonist treatment increases adult height in CAH children who develop central precocious puberty.
“GnRHa treatment increases adult height in CAH children who develop central precocious puberty (201).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [201]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingnone given
The optimal dose of fludrocortisone substitution in adults has not been critically studied.
“The optimal dose of fludrocortisone substitution in adults (as in infants and children) has not been critically studied.”
Quote in the paperNot a substantial claim - Findingnone given
Optimal levels for 17-OHP and androstenedione have not been defined.
“Optimal levels for 17-OHP and androstenedione have not been defined; testosterone levels in men normally reflect gonadal rather than adrenal function and therefore are not useful for monitoring therapy.”
Quote in the paperSubstantial claim - Findingcitation
Other psychosocial consequences of genital ambiguity have been documented by case reports but not in systematic studies.
“Other psychosocial consequences of genital ambiguity have been documented by case reports but not in systematic studies (262).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [262]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingcitation
Fertility in CAH males is poorly studied.
“Fertility in CAH males is poorly studied (188, 240 -242).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [188]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [240]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [241]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [242]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingnone given
Controlled observational studies are not available to document whether genital surgery prevents adverse psychosocial consequences.
“Controlled observational studies are not available to document whether genital surgery prevents adverse psychosocial consequences.”
Quote in the paperSubstantial claim - Findingnone given
No studies have been conducted to demonstrate that potential adverse psychosocial consequences of gender-incongruent genital appearance can be ameliorated by psychological counseling or psychotherapy.
“Finally, in contemplating the avoidance of early genital surgery, one must also consider that no studies have been conducted to demonstrate that potential adverse psychosocial consequences of gender-incongruent genital appearance can be ameliorated by psychological counseling or psychotherapy.”
Quote in the paperSubstantial claim - Interpretationcitation
Because many patients are compound heterozygotes for two or more different mutant CYP21A2 alleles, a wide spectrum of phenotypes may be observed.
“Because many patients are compound heterozygotes for two or more different mutant CYP21A2 alleles, a wide spectrum of phenotypes may be observed (15).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The most common form of congenital adrenal hyperplasia is caused by mutations in CYP21A2, the gene encoding the adrenal steroid 21-hydroxylase enzyme (P450c21).
“The most common form of CAH is caused by mutations in CYP21A2, the gene encoding the adrenal steroid 21-hydroxylase enzyme (P450c21) (5,6).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [5]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [6]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Morbidity and mortality are reduced due to early diagnosis and prevention of severe salt wasting.
“Morbidity and mortality are reduced due to early diagnosis and prevention of severe salt wasting.”
Quote in the paperSubstantial claim - Interpretationreasoning
The benefit of screening by direct comparison of death rates from congenital adrenal hyperplasia in unscreened and screened populations cannot be readily demonstrated because undiagnosed infants who die suddenly may not be ascertained.
“Because undiagnosed infants who die suddenly may not be ascertained, the benefit of screening by direct comparison of death rates from CAH in unscreened and screened populations cannot be readily demonstrated.”
Quote in the paperSubstantial claim - Interpretationreasoning
A relative paucity of salt-wasting males is indirect evidence of unreported deaths from salt-wasting crises.
“Thus, a relative paucity of saltwasting males is indirect evidence of unreported deaths from salt-wasting crises.”
Quote in the paperNot a substantial claim - Premisecitation
About 75% of classic congenital adrenal hyperplasia cases suffer aldosterone deficiency with salt wasting, failure to thrive, and potentially fatal hypovolemia and shock.
“About 75% of classic CAH cases suffer aldosterone deficiency with salt wasting, failure to thrive, and potentially fatal hypovolemia and shock (9).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Males with salt-wasting congenital adrenal hyperplasia are more likely than females to suffer from delayed or incorrect diagnosis because there is no genital ambiguity to alert the clinician.
“Moreover, males with salt-wasting CAH are more likely than females to suffer from delayed or incorrect diagnosis because there is no genital ambiguity to alert the clinician.”
Quote in the paperSubstantial claim - Premisecitation
Genotyping individuals with congenital adrenal hyperplasia is fraught with error due to the complexity of gene duplications, deletions, and rearrangements within chromosome 6p21.3.
“Genotyping individuals with CAH is fraught with error due to the complexity of gene duplications, deletions, and rearrangements within chromosome 6p21.3(12).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
A point mutation in exon 7 (Val281Leu) that preserves 20-50% of enzyme function accounts for about 70% of nonclassic congenital adrenal hyperplasia alleles.
“A point mutation in exon 7 (Val281Leu) that preserves 20 -50% of enzyme function ( 16) accounts for about 70% of NCCAH alleles (17,18).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [16]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [17]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [18]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Large deletions and a splicing mutation (intron 2, -13 from splice acceptor site, C-G substitution) that ablate enzyme activity comprise about 50% of classic congenital adrenal hyperplasia alleles.
“but large deletions and a splicing mutation (intron 2, Ϫ13 from splice acceptor site, C-G substitution) that ablate enzyme activity comprise about 50% of classic CAH alleles (14,15).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [14]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [15]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Because the period during which the genitalia of a female fetus may become virilized begins only 6 weeks after conception, treatment must be instituted essentially as soon as the woman knows she is pregnant.
“Because the period during which the genitalia of a female fetus may become virilized begins only 6 wk after conception, treatment must be instituted essentially as soon as the woman knows she is pregnant.”
Quote in the paperSubstantial claim - Premisecitation
Learning disabilities have been reported after salt-wasting crises.
“Learning disabilities have been reported after salt-wasting crises (30);”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Liquid chromatography followed by tandem mass spectrometry (LC-MS/MS) more effectively addresses many limitations of immunoassays for 17-hydroxyprogesterone, particularly when steroid ratios are measured.
“However, liquid chromatography followed by tandem mass spectrometry (LC-MS/MS) more effectively addresses many of these issues (42,43), particularly when steroid ratios are measured.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [42]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [43]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Much of the expense of following up positive newborn screening tests could be avoided with a second level of more specific screening.
“Much of the expense of following up positive newborn screening tests could be avoided with a second level of more specific screening.”
Quote in the paperSubstantial claim - Premisecitation
The death rate in salt-wasting congenital adrenal hyperplasia without screening is between 4 and 10%.
“The death rate in salt-wasting CAH without screening is between 4 and 10% (27,28).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [27]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Parents of infants with positive screens may suffer significant psychological distress at the prospect of their children having a potentially life-threatening chronic disease.
“Moreover, parents of infants with positive screens may suffer significant psychological distress at the prospect of their children having a potentially life-threatening chronic disease (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationnone given
Males with simple virilizing disease may otherwise not be diagnosed until rapid growth and accelerated skeletal maturation are detected later in childhood, at which time adult height may already be compromised.
“Moreover, males with simple virilizing disease may otherwise not be diagnosed until rapid growth and accelerated skeletal maturation are detected later in childhood, at which time adult height may already be compromised.”
Quote in the paperSubstantial claim - Premisecitation
First-tier screens for congenital adrenal hyperplasia employ immunoassays to measure 17-hydroxyprogesterone in dried blood spots on the same filter paper (Guthrie) cards as are used for other newborn screening tests.
“First-tier screens for CAH employ immunoassays to measure 17-OHP in dried blood spots on the same filter paper (Guthrie) cards as are used for other newborn screening tests (2)(3)(4).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [2]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [3]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [4]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductcitation
The evidence regarding fetal and maternal sequelae of prenatal dexamethasone treatment for fetuses at risk for congenital adrenal hyperplasia is of low or very low quality due to methodological limitations and small sample sizes.
“The evidence regarding fetal and maternal sequelae of prenatal dexamethasone treatment for fetuses at risk for CAH is of low or very low quality due to methodological limitations and small sample sizes (70,272).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [70]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [272]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Given the low prevalence of congenital adrenal hyperplasia (about one in 10,000 births), only approximately one in every 100 neonates with a positive screening test will have congenital adrenal hyperplasia.
“Despite the high accuracy of the screening test and given the low prevalence of CAH (about one in 10,000 births), only approximately one in every 100 neonates with a positive screening test will have CAH.”
Quote in the paperSubstantial claim- Rests on an assumption: To obtain adequate sensitivity, cutoff levels for 17-hydroxyprogesterone are typically set low enough that approximately 1% of all tests are reported as positive.
- Interpretationreasoning
Because more than 90% of mutant alleles carry one of 10 mutations (deletions or gene conversions), patients carrying none of these mutations are unlikely to be affected.
“Because more than 90% of mutant alleles carry one of 10 mutations (deletions or gene conversions), patients carrying none of these mutations are unlikely to be affected.”
Quote in the paperSubstantial claim - Interpretationcitation
The constant dexamethasone dose currently used may result in glucocorticoid levels that exceed typical midgestation physiological fetal glucocorticoid levels by about 60-fold.
“Thus, the constant dexamethasone dose currently used may result in GC levels that exceed typical midgestation physiological fetal GC levels by about 60fold (62,63).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [62]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [63]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Diagnostic accuracy of first-tier screening is poor in the first 2 days.
“Thus, diagnostic accuracy is poor in the first 2 d, which can be problematic if newborns are discharged early.”
Quote in the paperSubstantial claim- Rests on an assumption: 17-hydroxyprogesterone levels are normally high at birth and decrease rapidly during the first few postnatal days.
- Rests on an assumption: 17-hydroxyprogesterone levels increase with time in infants affected with congenital adrenal hyperplasia.
- Premisecitation
Suppression of fetal adrenal androgens in congenital adrenal hyperplasia is feasible by administering glucocorticoids to the mother.
“Nevertheless, suppression of fetal adrenal androgens in CAH is feasible by administering glucocorticoids (GCs) to the mother (54 -56).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Early fetal sex determination can improve the probability of treating an affected female fetus from one in eight to one in four.
“Because early fetal sex determination can improve the probability of treating an affected female fetus from one in eight to one in four,”
Quote in the paperSubstantial claim - Premisecitation
Dexamethasone is used because it is not inactivated by placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2).
“Dexamethasone is used because it is not inactivated by placental 11-hydroxysteroid dehydrogenase type 2 (11-HSD2) (64).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
Specificity of newborn screening might be improved by using actual gestational age to stratify subjects, rather than birth weight, because 17-hydroxyprogesterone levels are much better correlated with gestational age.
“Specificity of newborn screening might be improved by using actual gestational age to stratify subjects, rather than birth weight, because 17-OHP levels are much better correlated with gestational age (38).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
High doses of glucocorticoids exert negative effects in fetal animals.
“Clearly, high doses of GCs exert negative effects in fetal animals (95,96).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [95]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [96]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
The magnitude of this change in birth weight is equivalent to or greater than that seen with maternal cigarette smoking.
“The magnitude of this change in birth weight is equivalent to or greater than that seen with maternal cigarette smoking (93).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [93]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
During childhood, the preferred glucocorticoid is hydrocortisone because its short half-life minimizes the adverse side effects of more potent longer-acting glucocorticoids, especially growth suppression.
“During childhood, the preferred GC is HC because its short half-life minimizes the adverse side effects of more potent longer-acting GCs, especially growth suppression (118).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
During puberty, despite adequate replacement therapy and compliance, control may be suboptimal because of increased cortisol clearance.
“During puberty, despite adequate replacement therapy and compliance, control may be suboptimal because of increased cortisol clearance (128).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [128]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisereasoning
Prenatal treatment of congenital adrenal hyperplasia is directed toward reducing the need for surgery, rather than toward preserving life or intellectual capacity.
“Prenatal treatment of CAH is directed toward reducing the need for surgery, rather than toward preserving life or intellectual capacity.”
Quote in the paperSubstantial claim - Interpretationreasoning
All patients with elevated PRA or aldosterone to PRA ratio benefit from fludrocortisone therapy and adequate dietary sodium.
“Consequently, all patients with elevated PRA or aldosterone to PRA ratio benefit from fludrocortisone therapy and adequate dietary sodium.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Genotyping may reveal the IVS2 mutation, which is seen in both salt-wasters and non-salt-wasters.
“For example, genotyping may reveal the IVS2 mutation, which is seen in both salt-wasters and non-salt-wasters (15,113,114).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [15]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [113]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [114]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
The differences in triglyceride findings probably reflect small sample sizes in both studies.
“These differences probably reflect small sample sizes in both studies.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [175]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [176]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
In the neonatal period, recent exposure to placental estrogens leads to more elastic vaginal tissue, facilitating vaginal reconstruction.
“In the neonatal period, the recent exposure to placental estrogens leads to more elastic vaginal tissue, facilitating vaginal reconstruction (177).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [177]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Normal adrenocortical secretion has a circadian rhythm with levels low at onset of sleep, rising between 0200 and 0400 h, peaking in the early morning at approximately 0800 h, and then declining throughout the day.
“Normal adrenocortical secretion has a circadian rhythm with levels low at onset of sleep, rising between 0200 and 0400 h, peaking in the early morning at approximately 0800 h, and then declining throughout the day (205,206).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [205]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [206]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Chakhtoura et al. showed a negative correlation between the accumulated lifetime dose of GC and BMD.
“Chakhtoura et al. (234) showed a negative correlation between the accumulated lifetime dose of GC and BMD.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [234]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
For occasional patients with nondiagnostic values, genotyping may confirm the diagnosis.
“For occasional patients with nondiagnostic values, genotyping (219, 221, 222) may confirm the diagnosis.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [219]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [221]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [222]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Spontaneous abortions occurred more frequently before treatment in two studies of referred reproductive endocrinology clinic patients.
“Spontaneous abortions occurred more frequently before treatment in two such studies of referred reproductive endocrinology clinic patients (224,225).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [224]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [225]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Men with large testicular adrenal rests may have low morning testosterone indicating poor Leydig cell function.
“Men with large testicular adrenal rests may have low morning testosterone indicating poor Leydig cell function (233).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [233]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
Chronic adrenomedullary hypofunction may play a role in the development of insulin resistance.
“Chronic adrenomedullary hypofunction also may play a role in the development of insulin resistance (214).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [214]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
All of these factors may reflect the high doses of GCs used to suppress adrenal androgens.
“All of these factors may reflect the high doses of GCs used to suppress adrenal androgens.”
Quote in the paperNot a substantial claim - Premisecitation
This was not observed in a controlled retrospective Swedish study that included 90% classic CAH women.
“Interestingly, this was not observed in a controlled retrospective Swedish study that included 90% classic CAH women (160).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Control of hyperandrogenic symptoms in young women may require additional treatment such as antiandrogenic oral contraceptives.
“Control of hyperandrogenic symptoms in young women may require additional treatment such as antiandrogenic oral contraceptives (142).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [142]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Home monitoring of salivary 17-OHP may be more informative.
“Therefore, home monitoring of salivary 17-OHP may be more informative (232).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [232]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Gene therapy temporarily restored adrenal steroidogenesis in 21-hydroxylase-deficient mice.
“Gene therapy temporarily restored adrenal steroidogenesis in 21-hydroxylase-deficient mice (217).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [217]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
Based on a classical CAH incidence of 1:10,000 -1:20,000, the incidence of carriers in the general population is 1:50 -1:71.
“Based on a classical CAH incidence of 1:10,000 -1:20,000 (1)(2)(3)(4), the incidence of carriers in the general population is 1:50 -1:71.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [1]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [2]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [3]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [4]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The most significant metabolic abnormality was a 20% prevalence of gestational diabetes.
“The most significant metabolic abnormality was a 20% prevalence of gestational diabetes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [228]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
ACTH stimulation is needed for patients with baseline 17-OHP around the cutoff.
“ACTH stimulation is needed for patients with baseline 17-OHP around the cutoff; NCCAH patients reach higher than 1000 ng/dl (33 nmol/ liter).”
Quote in the paperSubstantial claim- Rests on an assumption: NCCAH patients reach higher than 1000 ng/dl (33 nmol/liter) after ACTH stimulation.
- Premisecitation
Fertility in classic CAH is reduced.
“Although fertility in classic CAH is reduced (147, 161), a retrospective multicenter review found that 68% of 203 pregnancies among 101 NCCAH women had occurred before the diagnosis was made, suggesting that GC treatment is not required for fertility.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [147]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [161]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
The longer-acting GCs were more commonly used in adults than in children.
“The longer-acting GCs were more commonly used in adults than in children.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [226]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Fertility may be impaired by suppression of gonadotropin secretion by adrenal steroids if adequate doses of GCs are not given.
“Fertility may be impaired by suppression of gonadotropin secretion by adrenal steroids if adequate doses of GCs are not given (242).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [242]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In a retrospective analysis of 162 children born to NCCAH women, the risk was 2.5%.
“However, in a retrospective analysis of 162 children born to NCCAH women, the risk was 2.5% (225).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [225]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The prevalence of testicular adrenal rest tumors varies between 0 and 94%, depending on the study population.
“The prevalence of these tumors varies between 0 and 94%, depending on the study population (188, 240, 243).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [188]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [240]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [243]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
CAH women are at increased risk for gestational diabetes.
“CAH women are at increased risk for gestational diabetes (160); thus, glucose tolerance should be monitored throughout pregnancy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [160]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Pregnancy and delivery rates were significantly lower in 62 women with CAH (ages 18 -63), despite fertility treatments.
“Pregnancy and delivery rates were significantly lower in 62 women with CAH (ages 18 -63), despite fertility treatments (160).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [160]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
A Danish study of 70 women with DSD, including some 46,XX CAH women, found impaired QoL and more affective distress in CAH patients.
“A Danish study of 70 women with DSD, including some 46,XX CAH women, found impaired QoL and more affective distress in CAH patients (257).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [257]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Recent surveys of women with CAH showed that most favored genital surgery before adolescence.
“Nevertheless, recent surveys of women with CAH showed that most favored genital surgery before adolescence (184, 185).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [184]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [185]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
A Swedish study of 62 women with CAH noted decreased QoL in the sexuality-related domains.
“A Swedish study of 62 women with CAH noted decreased QoL in the sexuality-related domains (184, 256).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [184]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [256]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Despite the presence of atypical genitalia and anecdotal reports of gender dysphoria and psychosexual dysfunction, core female gender identity is generally preserved among CAH girls.
“Despite the presence of atypical genitalia and anecdotal reports of gender dysphoria and psychosexual dysfunction, core female gender identity is generally preserved among CAH girls (263).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [263]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Mass spectrometric examinations of human urinary steroid metabolites indicate the backdoor pathway may also occur in the human adrenal.
“Although first discovered in marsupials, mass spectrometric examinations of human urinary steroid metabolites indicate this pathway may also occur in the human adrenal(7,8).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [7]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Maternal testosterone levels have been used to monitor CAH patients during pregnancy.
“Maternal testosterone levels have been used to monitor CAH patients during pregnancy (245).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [245]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Androgen and cortisol levels increase gradually during pregnancy due to increases in SHBG and cortisolbinding globulin.
“Androgen and cortisol levels increase gradually during pregnancy (245) due to increases in SHBG and cortisolbinding globulin.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [245]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Of 250 females with CAH who underwent psychological assessments, 5.2% reported gender problems.
“Of 250 females with CAH who underwent psychological assessments, 5.2% reported gender problems (251).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [251]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Using a median value of 1:60, a patient with classic CAH would have a one in 120 probability of having a child with classic CAH.
“Using a median value of 1:60, a patient with classic CAH would have a one in 120 probability of having a child with classic CAH.”
Quote in the paperNot a substantial claim - Premisecitation
An American study that compared 72 females and 42 males with CAH (aged 3-31 yr) and unaffected relatives found no significant differences in psychological adjustment on age-appropriate validated questionnaires.
“An American study that compared 72 females and 42 males with CAH (aged 3-31 yr) and unaffected relatives found no significant differences in psychological adjustment on age-appropriate validated questionnaires (259).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [259]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- May combine two claims. 90
- Classified as probably not a substantial claim. 16
May combine two claims.
FindingcitationAntenatal corticosteroid treatment might reduce 17-hydroxyprogesterone levels, but inconsistent effects have been observed in practice.
“Finally, antenatal corticosteroid treatment (as used to induce lung maturation in fetuses at risk for premature birth) might reduce 17-OHP levels, but inconsistent effects have been observed in practice (40,41).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [41]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationA single approach to prenatal treatment has been studied, but optimal dosing and duration of treatment have not been determined.
“A single approach to prenatal treatment has been studied (57,58), but optimal dosing and duration of treatment have not been determined.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationThere are no universally accepted standards for stratifying infants, but most U.S. laboratories use a series of birth weight-adjusted cutoffs.
“There are no universally accepted standards for stratifying infants, but most U.S. laboratories use a series of birth weight-adjusted cutoffs (9,36,37).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [36]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [37]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationBoth RIAs and ELISAs have been almost completely supplanted by automated time-resolved dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA) in at least 45 states and most European countries.
“Both RIAs and ELISAs have been almost completely supplanted (9) (in at least 45 states and most European countries) by automated time-resolved dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA) (35).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [35]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationSeveral studies of genotyping of samples from screening programs have suggested that this is a potentially useful adjunct to hormonal measurements, but no large-scale study of efficacy has been reported as a second-tier screen in actual use.
“Several studies of genotyping of samples from screening programs have suggested that this is a potentially useful adjunct to hormonal measurements (48 -51), but no large-scale study of efficacy has been reported as a second-tier screen in actual use.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [49]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [50]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [51]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationCalculations of costs per life-year saved are sensitive to the assumed death rate, and recent estimates have ranged widely from $20,000 to $250,000-300,000.
“Calculations of costs per lifeyear saved are sensitive to the assumed death rate, and recent estimates have ranged widely from $20,000 (32) to $250,000 -300,000 (33).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [32]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [33]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationThe data suggested greatest risk for exposure between 1-8 weeks, but the numbers were small (odds ratio = 7.3; 95% confidence interval = 1.8-29.4).
“The data suggested greatest risk for exposure between 1-8 weeks, but the numbers were small (odds ratio ϭ 7.3; 95% confidence interval ϭ 1.8 -29.4) (83).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationThose never treated were most virilized, averaging 3.75.
“Those never treated were most virilized, averaging 3.75.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationAmong 118 women treated to term who responded to a mailed questionnaire, the mean pregnancy-associated weight gain was 7.1 lbs (3.2 kg) greater than that experienced by untreated women (P<0.005); these women also reported increased striae (P=0.01) and increased edema (P=0.02) but no reported increase in hypertension or gestational diabetes.
“Among 118 women treated to term who responded to a mailed questionnaire, the mean pregnancy-associated weight gain was 7.1 lbs (3.2 kg) greater than that experienced by untreated women (P Ͻ 0.005); these women also reported increased striae (P ϭ 0.01) and increased edema (P ϭ 0.02) but no reported increase in hypertension or gestational diabetes (58).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationIn the largest single series, among 25 CAH-affected females receiving dexamethasone before the ninth week of pregnancy, 11 had normal female genitalia, 11 had minimal virilization (Prader stages 1-2), and three were virilized (Prader stage 3); the mean Prader score for this group was 1.0.
“Among 25 CAH-affected females receiving dexamethasone before the ninth week of pregnancy, 11 had normal female genitalia, 11 had minimal virilization (Prader stages 1-2), and three were virilized (Prader stage 3); the mean Prader score for this group was 1.0.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationOne year after prenatal exposure of nonhuman primates to 120 g/kg dexamethasone, there were reduced pancreatic β-cell numbers, impaired glucose tolerance, increased systolic and diastolic blood pressure, and reduced postnatal growth despite normal birth weight.
“One year after prenatal exposure of nonhuman primates to 120 g/kg dexamethasone, there were reduced pancreatic -cell numbers, impaired glucose tolerance, increased systolic and diastolic blood pressure, and reduced postnatal growth despite normal birth weight (92).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationIn response to a questionnaire, compared with untreated controls, treated women reported increased appetite (P<0.01), rapid weight gain (P<0.02), and edema (P=0.04), and 30 of the 44 women indicated they would decline prenatal treatment of a subsequent pregnancy.
“However, in response to a questionnaire, compared with untreated controls, treated women reported increased appetite (P Ͻ 0.01), rapid weight gain (P Ͻ 0.02), and edema (P ϭ 0.04), and 30 of the 44 women indicated they would decline prenatal treatment of a subsequent pregnancy (72).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationA carefully controlled study of 44 women receiving prenatal dexamethasone (only six to term) found increased weight gain in mothers treated during the first trimester, but this difference was absent at term; there were no differences in maternal blood pressure, glycosuria, proteinuria, length of gestation, or placental weight.
“A carefully controlled study of 44 women receiving prenatal dexamethasone (only six to term) found increased weight gain in mothers treated during the first trimester, but this difference was absent at term.There were no differences in maternal blood pressure, glycosuria, proteinuria, length of gestation, or placental weight.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationA review lacking a control group indicated that 9-30% of treated women complained of mild gastric distress, weight gain, mood swings, pedal edema, and mild hypertension and that only 1.5% of 253 treated women had serious complications including striae, large weight gain, hypertension, preeclampsia, and gestational diabetes.
“A review lacking a control group indicated that 9 -30% of treated women complained of mild gastric distress, weight gain, mood swings, pedal edema, and mild hypertension and that only 1.5% of 253 treated women had serious complications including striae, large weight gain, hypertension, preeclampsia, and gestational diabetes (57).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationFollow-up reports of prenatally treated children have reported birth weights in the normal range but are nevertheless reduced by about 0.4-0.6 kg in the largest studies.
“Follow-up reports of prenatally treated children have reported birth weights in the normal range (56,57,71,72) but are nevertheless reduced by about 0.4 -0.6 kg in the largest studies (58).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [71]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [72]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationNo teratogenic effects have been identified with high-dose glucocorticoids administered during gestation; however, these studies concerned steroids that are inactivated by placental 11β-HSD2 and as such do not affect the fetus.
“No teratogenic effects have been identified with high-dose GCs administered during gestation; however, these studies concerned steroids that are inactivated by placental 11-HSD2 and as such do not affect the fetus (80,81).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [80]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [81]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationThe prevalence of testicular adrenal rests in boys with classic CAH aged 2-18 years varies from 21-28%; there have been no such studies in NCCAH males.
“The prevalence of testicular adrenal rests in boys with classic CAH aged 2-18 yr varies from 21-28% (154 -156); there have been no such studies in NCCAH males.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [154]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [155]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [156]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationHeterozygotes have slightly elevated 17-OHP levels after ACTH stimulation, but there is overlap with unaffected subjects.
“Heterozygotes have slightly elevated 17-OHP levels after ACTH stimulation, but there is overlap with unaffected subjects (115).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [115]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationTesticular masses in boys with classic CAH are usually bilateral and smaller than 2 cm in diameter and therefore not palpable but detectable by ultrasound.
“Testicular masses in boys with classic CAH are usually bilateral and smaller than 2 cm in diameter and therefore not palpable but detectable by ultrasound (US) (154 -156).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [154]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [155]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [156]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationThe estimated growth-suppressive effect of prednisolone is about 15-fold more potent than hydrocortisone, and dexamethasone is 70- to 80-fold more potent.
“In one trial, the estimated growth-suppressive effect of prednisolone was about 15-fold more potent than HC (119); dexamethasone is 70-to 80-fold more potent (120).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [119]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [120]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationThe parents of the prenatally treated children described them as being more sociable than controls (P=0.042); there were no differences in psychopathology, behavioral problems, or adaptive functioning.
“The parents of the prenatally treated children described them as being more sociable than controls (P ϭ 0.042); there were no differences in psychopathology, behavioral problems, or adaptive functioning (105).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationHydrocortisone suspension and hydrocortisone tablets are not bioequivalent, and hydrocortisone oral suspension may be inadequate to control CAH in children due to uneven distribution of the drug in liquid.
“HC suspension and HC tablets are not bioequivalent, and HC oral suspension may be inadequate to control CAH in children (121) due to uneven distribution of the drug in liquid.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [121]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationSensitivity to mineralocorticoids may vary over time, and recovery from salt wasting has been described in some patients, most probably secondary to extraadrenal 21-hydroxylation.
“Sensitivity to MCs may vary over time, and recovery from salt wasting has been described in some patients, most probably secondary to extraadrenal 21-hydroxylation (132, 133).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [132]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [133]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationCAH-unaffected children prenatally treated short term had poorer verbal working memory, rated lower on self-perception of scholastic competence (both P=0.003), and had increased self-rated social anxiety (P=0.026).
“However, CAH-unaffected children prenatally treated short term had poorer verbal working memory, rated lower on self-perception of scholastic competence (both P ϭ 0.003), and had increased self-rated social anxiety (P ϭ 0.026) (104).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [104]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationThe prevalence of adrenal masses in autopsy samples increases with age, being 0.2% in young adults and 7% in subjects older than 70 years.
“Their prevalence in autopsy samples increases with age, being 0.2% in young adults and 7% in subjects older than 70 yr (149).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [149]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationSubclinical aldosterone deficiency is present in all forms of 21-hydroxylase deficiency and can be best evaluated by the aldosterone to PRA ratio.
“Although the aldosterone biosynthetic defect is clinically apparent only in the salt-wasting form, subclinical aldosterone deficiency is present in all forms of 21-hydroxylase deficiency (112, 130, 275) and can be best evaluated by the aldosterone to PRA ratio.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [112]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [130]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [275]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationA small but rigorous study using a standardized treatment protocol, questionnaires, and standardized neuropsychological tests compared prenatally treated children and a control group matched for age and sex; no differences were found in intelligence, handedness, or long-term memory.
“A small but rigorous study, using a standardized treatment protocol, questionnaires, and standardized neuropsychological tests administered by a clinical psychologist, compared prenatally treated children and a control group matched for age and sex.No differences were found in intelligence, handedness, or long-term memory.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [104]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationAdult height of CAH patients correlates negatively with the dose of glucocorticoid administered in early puberty; patients treated with less than 20 mg hydrocortisone/m2 per day at start of puberty are significantly taller than those given higher hydrocortisone doses.
“Adult height of CAH patients correlates negatively with the dose of GC administered in early puberty; patients treated with less than 20 mg HC/m 2 ⅐ d at start of puberty are significantly taller than those who were given higher HC doses.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationAdrenal carcinomas have rarely been reported in adults and in only two pediatric patients with CAH.
“Adrenal carcinomas have rarely been reported in adults (151) and in only two pediatric patients with CAH (152,153).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [151]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [152]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [153]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationStudies in pediatric patients showed that approximately half are overweight, and 16-25% are obese.
“Studies in pediatric patients showed that approximately half are overweight, and 16 -25% are obese (170 -172).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [170]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [171]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [172]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationInconsistent data have been reported on triglyceride levels, with one study reporting higher levels in a group of prepubertal patients on glucocorticoid treatment compared with age-matched controls and another showing a lipid profile in CAH children similar to that of controls.
“Inconsistent data have been reported on triglyceride levels, with one study reporting higher levels in a group of prepubertal patients on GC treatment compared with agematched controls (175) and another showing a lipid profile in CAH children similar to that of controls (176).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [175]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [176]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationSubtle insulin resistance can be detected in untreated NCCAH, but frankly impaired glucose tolerance is uncommon.
“Whereas subtle insulin resistance can be detected in untreated NCCAH (274), frankly impaired glucose tolerance is uncommon.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [274]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationAge at diagnosis, sex, type or dose of steroid, and age of onset of puberty did not significantly influence adult height; however, these subgroup analyses were inconclusive.
“Age at diagnosis, sex, type or dose of steroid, and age of onset of puberty did not significantly influence adult height; however, these subgroup analyses were inconclusive.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [131]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationIn nonsystematic reviews, patients who were diagnosed late or were exposed to glucocorticoid doses higher than 15 mg/m2 per day had diminished height.
“In nonsystematic reviews, patients who were diagnosed late or were exposed to GC doses higher than 15 mg/m 2 ⅐ d had diminished height (191,192).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [191]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [192]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationUrinary incontinence and vaginal stenosis requiring dilation or reoperation remain a postoperative concern but have not been reported by either Peña or Rink.
“Urinary incontinence and vaginal stenosis requiring dilation or reoperation remain a postoperative concern but have not been reported by either Pen ˜a (179) or Rink (180 -182).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [179]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [180]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [181]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [182]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationHypertension is more prevalent in children with classic CAH than in the general population, and systolic blood pressure was related to body mass index independent of glucocorticoid or mineralocorticoid therapy.
“Hypertension is more prevalent in children with classic CAH than in the general population, and systolic blood pressure was related to body mass index independent of GC or MC therapy (173, 174).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [173]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [174]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationA meta-analysis of data from 18 centers worldwide showed that the mean adult height of patients with classic CAH was 1.37 SD (10 cm) below the mean, and patients diagnosed before 1 year of age had increased adult height outcomes (0.54 SD).
“A metaanalysis of data from 18 centers worldwide showed that the mean adult height of patients with classic CAH was 1.37 SD (10 cm) below the mean, and patients diagnosed before 1 yr of age had increased adult height outcomes (0.54 SD) (190).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [190]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingnone givenThere are no randomized controlled studies on longterm follow-up of different modes of treatment of adults with classic CAH, and practice varies.
“There are no randomized controlled studies on longterm follow-up of different modes of treatment of adults with classic CAH, and practice varies.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationCombined cortisol and epinephrine deficiency results in glucose, insulin, and leptin dysregulation, shown during short-term high-intensity exercise and long-term moderate-intensity exercise.
“Combined cortisol and epinephrine deficiency results in glucose, insulin, and leptin dysregulation, shown during short-term high-intensity exercise (211, 212) and longterm moderate-intensity exercise (213).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [211]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [212]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [213]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingnone givenThere is no evidence of clinically significant cortisol deficiency or adrenal crisis in NCCAH.
“There is no evidence of clinically significant cortisol deficiency or adrenal crisis in NCCAH, and we do not suggest that previously untreated adults with NCCAH be given substitution during severe stress, unless they have demonstrated a subnormal cortisol response during cosyntropin stimulation.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationLaparoscopic bilateral adrenalectomy in two women with classic salt-wasting CAH for difficult-to-suppress androgens resulted in weight loss and regular menstruation in both, and one had a successful pregnancy 3 years postoperatively.
“Laparoscopic bilateral adrenalectomy was performed in two women (aged 22 and 28 yr) with classic salt-wasting CAH for difficult-to-suppress androgens, with amenorrhea, hirsutism, and acne (204).Weight loss and regular menstruation followed in both patients, and one had a successful pregnancy 3 yr postoperatively.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [204]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationOne patient had mildly elevated adrenal steroid precursors, likely due to adrenal rest tissue.
“One patient had mildly elevated adrenal steroid precursors, likely due to adrenal rest tissue.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [204]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
FindingcitationThree adult female patients with salt-wasting CAH underwent adrenalectomy for unsuppressible hyperandrogenism and worsening obesity; weight loss was achieved, but all three experienced pigmentation and adrenal crises during follow-up.
“Three patients underwent adrenalectomy for unsuppressible hyperandrogenism and worsening obesity.Weight loss was achieved; however, all three patients experienced pigmentation and adrenal crises during follow-up.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [203]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingnone givenAvailable studies report on small series, and different modes for monitoring treatment have not been studied systematically.
“Available studies report on small series, and different modes for monitoring treatment have not been studied systematically.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationAll patients reported subjective benefits after adrenalectomy, including the need for less frequent monitoring, weight loss, and fewer signs and symptoms of androgen excess.
“All patients reported subjective benefits after surgery, including the need for less frequent monitoring, weight loss, and fewer signs and symptoms of androgen excess.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [202]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationA modified-release oral form of hydrocortisone is being developed.
“A modified-release oral form of HC is being developed (209).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [209]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingnone givenThere are scant empiric data and no widely accepted recommendations for the management of GC doses in the pregnant CAH patient.
“There are scant empiric data and no widely accepted recommendations for the management of GC doses in the pregnant CAH patient.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenSeveral reviews, but no controlled studies, describe how to transfer CAH patients from pediatric to adult care.
“Several reviews, but no controlled studies, describe how to transfer CAH patients from pediatric to adult care.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThere is a mild nonclassic form of congenital adrenal hyperplasia that may show variable degrees of postnatal androgen excess but is sometimes asymptomatic.
“In addition to the so-called classic salt-wasting and simple virilizing forms of CAH, there is also a mild nonclassic form, which may show variable degrees of postnatal androgen excess but is sometimes asymptomatic (10).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMore than 100 CYP21A2 mutations are known.
“More than 100 CYP21A2 mutations are known (13),”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningCongenital adrenal hyperplasia is a disease suited to newborn screening because it is common and potentially fatal.
“CAH is a disease suited to newborn screening because it is common and potentially fatal.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationNonclassic forms of congenital adrenal hyperplasia occur in approximately 0.1-0.2% of the general Caucasian population but in up to 1-2% among inbred populations such as Eastern European (Ashkenazi) Jews.
“Nonclassic forms of CAH are more prevalent, occurring in approximately 0.1-0.2% in the general Caucasian population but in up to 1-2% among inbred populations, such as Eastern European (Ashkenazi) Jews (11).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe incidence of congenital adrenal hyperplasia ranges from 1:10,000 to 1:20,000 births.
“The incidence ranges from 1:10,000 to 1:20,000 births (1)(2)(3)(4)”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [1]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [2]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [3]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCongenital adrenal hyperplasia is more prevalent in some ethnic groups, particularly in remote geographic regions such as Alaskan Yupiks.
“and is more prevalent in some ethnic groups, particularly in remote geographic regions (e.g.Alaskan Yupiks).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [1]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [2]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [3]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
InterpretationreasoningThese problems can be ameliorated by adopting screening methods with higher positive predictive values.
“These problems can be ameliorated by adopting screening methods with higher positive predictive values.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningGenotyping is focused on a single gene, CYP21A2, and will not be helpful in diagnosing other enzyme deficiencies causing congenital adrenal hyperplasia, as can be done with LC-MS/MS.
“Additionally, it is focused on a single gene, i.e.CYP21A2, and will not be helpful in diagnosing other enzyme deficiencies causing CAH, as can be done with LC-MS/MS.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningOnly half of affected fetuses will be females; hence, treatment is potentially beneficial for only one in eight fetuses.
“Furthermore, only half of the affected fetuses will be females; hence, treatment is potentially beneficial for only one in eight fetuses.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningBecause antenatally administered glucocorticoids are widely used to induce fetal lung development in the third trimester, many studies have addressed the effects of late-gestation, high-dose, short-term administration, but this may not be germane to prenatal treatment of congenital adrenal hyperplasia.
“Because antenatally administered GCs are widely used to induce fetal lung development in the third trimester, many studies have addressed the effects of late-gestation, high-dose, shortterm administration, but this may not be germane to prenatal treatment of CAH.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenPrenatal treatment does not change the need for lifelong hormonal replacement therapy, the need for careful medical monitoring, or the risk of life-threatening salt-losing crises if therapy is interrupted.
“prenatal treatment does not change the need for lifelong hormonal replacement therapy, the need for careful medical monitoring, or the risk of life-threatening salt-losing crises if therapy is interrupted.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningBecause treatment must be started at 6-7 weeks gestation, and genetic diagnosis by chorionic villous biopsy cannot be done until 10-12 weeks, all pregnancies at risk for congenital adrenal hyperplasia are treated, even though only one in four is affected.
“Because treatment must be started at 6 -7 wk gestation, and genetic diagnosis by chorionic villous biopsy cannot be done until 10 -12 wk, all pregnancies at risk for CAH are treated, even though only one in four is affected.”
Quote in the paperSubstantial claim- Rests on an assumption: Congenital adrenal hyperplasia is autosomal recessive; if a woman has previously had a child with congenital adrenal hyperplasia and again becomes pregnant via the same partner, her fetus will have a one in four chance of having congenital adrenal hyperplasia.
May combine two claims.
PremisecitationFetal cortisol levels are low in very early gestation, rise during weeks 8-12 while the external genitalia are differentiating, are only about 10% of maternal levels during midgestation, and then increase during the third trimester.
“Fetal cortisol levels are low in very early gestation, rise during wk 8 -12 while the external genitalia are differentiating (59), are only about 10% of maternal levels during midgestation (60,61), and then increase during the third trimester.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [59]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [60]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [61]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Study design and conductcitationReports from the group first describing prenatal treatment do not provide actual numbers describing their outcomes and did not include control groups of nontreated pregnancies.
“However, these reports do not provide actual numbers describing their outcomes and did not include control groups of nontreated pregnancies.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationNewborn birth weight correlates with adult incidences of ischemic heart disease and hypertension.
“Because newborn birth weight correlates with adult incidences of ischemic heart disease and hypertension (84,85)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [84]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [85]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningThe groups advocating and performing prenatal treatment appear to agree that it is effective in reducing and often eliminating virilization of female fetal genitalia and that the success rate is about 80-85%.
“Thus, the groups advocating and performing prenatal treatment appear to agree that it is effective in reducing and often eliminating virilization of female fetal genitalia and that the success rate is about 80 -85%.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationModerately low-dose dexamethasone (100 g/kg) reduced birth weight and increased blood pressure in rats.
“and because moderately low-dose dexamethasone (100 g/kg) reduced birth weight and increased blood pressure in rats (86),”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [86]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationPrenatal dexamethasone alters postnatal renal structure and function and produces hypertension in rodents.
“Prenatal dexamethasone alters postnatal renal structure and function and produces hypertension in rodents (90,91).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [90]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [91]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningMultiple studies indicate that prenatal treatment is associated with modest but manageable maternal complications that do not appear to pose a major risk to the mother.
“Thus, multiple studies indicate that prenatal treatment is associated with modest but manageable maternal complications that do not appear to pose a major risk to the mother.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMany reports of teratogenic effects, especially orofacial clefts, produced by high doses of dexamethasone administered to pregnant animals and in human patients led the U.S. Food and Drug Administration to classify dexamethasone as a category B drug, whose safety in pregnancy is not established.
“Many reports of teratogenic effects, especially orofacial clefts, produced by high doses of dexamethasone admin-istered to pregnant animals (74 -76) and in human patients (77)(78)(79) led the U.S. Food and Drug Administration to classify dexamethasone as a category B drug, whose safety in pregnancy is not established.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [74]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [75]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [76]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites (77)(78)(79)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationcitationIn salt-wasting CAH patients, the sodium content of breast milk or infant formulas is insufficient, and sodium chloride supplements are necessary.
“However, in saltwasting CAH patients, the sodium content of breast milk or infant formulas is insufficient, and sodium chloride supplements are necessary (129).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [129]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningAlthough prednisolone and dexamethasone are effective in suppressing adrenal androgens in children with CAH, these more potent drugs are more likely to impede statural growth and cannot be routinely recommended.
“Thus, although prednisolone and dexamethasone treatment are effective in suppressing adrenal androgens in children with CAH, these more potent drugs are more likely to impede statural growth and cannot be routinely recommended.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationTesticular adrenal rest tumors are benign, often related to suboptimal therapy, and usually decrease in size after optimization of glucocorticoid therapy.
“These so-called testicular adrenal rest tumors are benign, often related to suboptimal therapy, and usually decrease in size after optimization of GC therapy (157).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [157]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAdrenal masses affect 1-4% of normal men and women.
“Adrenal masses affect 1-4% of normal men and women (148).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [148]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationcitationPatients with severe forms of 21-hydroxylase deficiency are unable to produce a sufficient cortisol response to physical stress, such as febrile illness, gastroenteritis with dehydration, surgery, or trauma, and therefore require increased doses of glucocorticoid during such episodes.
“Patients with severe forms of 21-hydroxylase deficiency are unable to produce a sufficient cortisol response to physical stress, such as febrile illness, gastroenteritis with dehydration, surgery, or trauma, and therefore require increased doses of GC during such episodes (Table 3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 3
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningThe concern is treating seven unaffected and/or male fetuses to treat one affected female in the context of inadequate data regarding the long-term risks of this therapy.
“The concern is treating seven unaffected and/or male fetuses to treat one affected female in the context of inadequate data regarding the long-term risks of this ther-apy.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningOther analytes have been used as markers of heterozygosity, but genotyping is usually a superior method of heterozygote detection.
“Other analytes have been used as markers of heterozygosity (116, 117), but genotyping is a usually superior method of heterozygote detection.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [116]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [117]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationcitationMaintenance of sodium balance reduces vasopressin and ACTH levels, contributing to lower glucocorticoid doses, leading to better auxological outcomes.
“Maintenance of sodium balance reduces vasopressin and ACTH levels, contributing to lower GC doses, leading to better auxological outcomes (108,123,131).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [108]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [123]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [131]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationElevated plasma renin activity (PRA) and a reduced ratio of aldosterone to PRA indicate impaired aldosterone synthesis and can differentiate salt wasters from simple virilizers after the newborn period.
“Elevated plasma renin activity (PRA) and a reduced ratio of aldosterone to PRA indicate impaired aldosterone synthesis and can differentiate salt wasters from simple virilizers (112) after the newborn period.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationcitationA polycystic ovary syndrome type of functional ovarian hyperandrogenism may cause irregular menses in women with well-controlled CAH; the hyperandrogenism and menstrual irregularity of such individuals benefits from additional therapy with second- or third-generation oral contraceptives.
“A polycystic ovary syndrome type of functional ovarian hyperandrogenism may cause irregular menses in women with well-controlled CAH (163, 164); the hyperandrogenism and menstrual irregularity of such individuals benefits from additional therapy with secondor third-generation oral contraceptives.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [163]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [164]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationcitationOvertreatment during infancy or treatment with long-acting, high-potency glucocorticoids may also reduce height.
“Overtreatment during infancy (126,193) or treatment with long-acting, high-potency GCs may also reduce height (118).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [126]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [193]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [118]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim. May combine two claims.
InterpretationcitationThe recommendation for neurovascular-sparing clitoroplasty and vaginoplasty using total or partial urogenital mobilization is based on the poor results of other forms of vaginoplasty and is consistent with the consensus statement on 21-hydroxylase deficiency.
“This recommendation is based on the poor results of other forms of vaginoplasty (147, 183), including flap vaginoplasty for severe CAH and vaginal pull-through separating the urethra and vaginal components, and is consistent with the consensus statement on 21-hydroxylase deficiency from the Pediatric Endocrine Society (formerly known as Lawson Wilkins Pediatric Endocrine Society) and the European”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [147]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [183]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [107]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationAdministration of dexamethasone, 0.25 mg/d, can be effective in reducing acne and irregular menstruations within 3 months and hirsutism within 30 months.
“However, administration of dexamethasone, 0.25 mg/d, can be effective in reducing acne and irregular menstruations within 3 months and hirsutism within 30 months (223).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [223]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationThe need for MCs decreases with age, because serum aldosterone is high and renal MC receptor mRNA is low at birth.
“The need for MCs decreases with age, because serum aldosterone is high and renal MC receptor mRNA is low at birth (229), and the degree of MC and/or salt supplementation must be monitored by blood pressure and renin measurements in blood.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [229]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationAmong European pediatric endocrinologists, 36% said they used HC (mean dose 13.75 mg/m2), 14% used prednisolone (4.75 mg/d), and 33% used dexamethasone (0.5 mg/d) as the primary form of GC for substitution in adults with CAH.
“Among European pediatric endocrinologists, 36% said they used HC (mean dose 13.75 mg/m 2 ), 14% used prednisolone (4.75 mg/d), and 33% used dexamethasone (0.5 mg/d) as the primary form of GC for substitution in adults with CAH (226).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [226]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationcitationThe occurrence and severity of osteopenia/osteoporosis was not related to CAH genotype or phenotype but probably was due to overtreatment with GCs.
“The occurrence and the severity of osteopenia/osteoporosis was not related to CAH genotype or phenotype but probably was due to overtreatment with GCs.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [227]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationFalhammar et al. found that CAH patients over 30 yr of age had a higher waist to hip ratio than age-matched controls, fat mass was similar, and few CAH patients had hypertension, cardiovascular disease, or diabetes.
“Although Falhammar et al. (228) found that CAH patients over 30 yr of age had a higher waist to hip ratio than age-matched controls, fat mass was similar, and few CAH patients had hypertension, cardiovascular disease, or diabetes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [228]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationcitationPatients with classic CAH have adrenomedullary insufficiency because glucocorticoids play essential roles in the development and regulation of the adrenal medulla.
“Patients with classic CAH have adrenomedullary insufficiency because GCs play essential roles in the development and regulation of the adrenal medulla (198,210).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [198]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [210]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationOvertreatment with GCs may lead to osteoporosis, as noted in retrospective studies of 62 adult women with CAH, accompanied by an increased incidence of fractures as compared with healthy controls.
“Overtreatment with GCs may lead to osteoporosis, as noted in retrospective studies of 62 adult women with CAH, accompanied by an increased incidence of fractures as compared with healthy controls (227).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [227]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationBaseline follicular-phase early-morning 17-OHP levels can be used to detect CAH, but the normal cutoff varies between 200 and 400 ng/dl, depending on the assay.
“Baseline follicular-phase early-morning 17-OHP levels can be used to detect CAH, but the normal cutoff varies between 200 and 400 ng/dl, depending on the assay (6 and 13 nmol/liter) (167, 218 -220).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [167]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [218]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [219]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [220]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationGestational diabetes was increased among CAH women vs. controls but without other metabolic or cardiovascular abnormalities.
“Gestational diabetes was increased among CAH women vs. controls but without other metabolic or cardiovascular abnormalities (228).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [228]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExisting clinical guidelines recommend interdisciplinary teams involving mental health staff with expertise in managing psychosocial problems specific to disorders of sexual development (DSD).
“Existing clinical guidelines (107, 246 -250) recommend interdisciplinary teams involving mental health staff with expertise in managing psychosocial problems specific to disorders of sexual development (DSD).”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [107]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [246]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [247]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [248]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [249]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [250]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationAmong 33 46,XX CAH patients raised as males, four identified themselves as female, and three were gender dysphoric.
“Among 33 46,XX CAH patients raised as males, four identified themselves as female, and three were gender dysphoric (251).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [251]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationA Finnish study found a better health-related QoL in both male and female patients with CAH than in the general Finnish population, despite numerous medical complications; however, 45% of eligible patients did not participate.
“A Finnish study found a better health-related QoL in both male and female patients with CAH than in the general Finnish population, despite numerous medical complications; however, 45% of eligible patients did not participate (241).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [241]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationAmong 45 German women with CAH, the overall QoL of the CAH women did not differ from controls, but significant impairments were found concerning body image and attitudes toward sexuality, and CAH women were more often single and fewer of them had children than did controls.
“Among 45 German women with CAH (260), the overall QoL of the CAH women did not differ from controls, but significant impairments were found concerning body image and atti-tudes toward sexuality, and CAH women were more often single and fewer of them had children than did controls.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [260]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationIn an Australian study, most of the DSD patients including XX women with CAH had positive psychosocial and psychosexual outcomes, although there were some problems with sexual activity.
“In an Australian study, most of the DSD patients including XX women with CAH had positive psychosocial and psychosexual outcomes, although there were some problems with sexual activity ( 258).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [258]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHagenfeldt et al. summarized this literature, finding an unexplained 2:1 female to male ratio for offspring of CAH women.
“Hagenfeldt et al. (160) summarized this literature, finding an unexplained 2:1 female to male ratio for offspring of CAH women.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationBidet et al. found a combined incidence of mild and severe mutations in 8% of partners of French NCCAH patients, suggesting a much higher risk for offspring to have CAH of any form.
“Bidet et al. (219) found a combined incidence of mild and severe mutations in 8% of partners of French NCCAH patients, suggesting a much higher risk for offspring to have CAH of any form.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [219]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationOne study reported normal fertility, but others reported substantially reduced fertility.
“One study reported normal fertility (188), but others reported substantially reduced fertility (243).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [188]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [243]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationRecent reports of long-term follow-up studies show variable outcomes including impaired cosmesis and sexual functioning, and even nonsurgical procedures such as vaginal dilatation can be problematic.
“Recent reports of long-term follow-up studies show variable outcomes including impaired cosmesis and sexual functioning (264 -267), and even nonsurgical procedures such as vaginal dilatation can be problematic (268).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [264]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [265]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [266]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [267]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [268]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationPsychosocial factors may also play a role, because fewer men with CAH had steady heterosexual relationships than did age-matched controls.
“Psychosocial factors may also play a role, because fewer men with CAH had steady heterosexual relationships than did age-matched controls (241).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [241]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationThe cosmetic results are variably evaluated by patients, who tend to be more critical than their physicians.
“The cosmetic results are variably evaluated by patients, who tend to be more critical than their physicians (184, 185).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [184]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [185]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationObstetricians should be aware that despite an apparent normal pregnancy rate of about 90%, classic CAH women have low fecundity (0.25 live births per woman vs. 1.8 in the general population).
“Obstetricians should be aware that despite an apparent normal pregnancy rate of about 90%, classic CAH women have low fecundity (0.25 live births per woman vs. 1.8 in the general population) (239).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [239]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCAH is one specific subtype under the rubric of DSD.
“CAH is one specific subtype under the rubric of DSD (250) but should not be equated with other forms of DSD in which outcomes are less well defined.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [250]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationcitationTools to assess health-related QoL were not designed for issues related to DSD or CAH; hence, the results of the few studies of QoL in CAH women are somewhat variable.
“Tools to assess health-related QoL were not designed for issues related to DSD or CAH (255); hence, the results of the few studies of QoL in CAH women are somewhat variable.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [255]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
The paper relies on this without support.
21-hydroxylase deficiency accounts for approximately 95% of congenital adrenal hyperplasia.
“Because this enzyme deficiency accounts for approximately 95% of CAH, we will discuss only 21-hydroxylase deficiency here.”
The paper relies on this without support.
Disease severity correlates with CYP21A2 allelic variation.
“Disease severity correlates with CYP21A2 allelic variation.”
The paper relies on this without support.
A nonconservative amino substitution in exon 4 (Ile172Asn) that preserves approximately 1-2% of enzyme function is associated with simple virilizing classic congenital adrenal hyperplasia.
“A nonconservative amino substitution in exon 4 (Ile172Asn) that preserves approximately 1-2% of enzyme function is associated with simple virilizing classic CAH.”
The paper relies on this without support.
17-hydroxyprogesterone levels are normally high at birth and decrease rapidly during the first few postnatal days.
“In interpreting these tests, it must be remembered that 17-OHP levels are normally high at birth and decrease rapidly during the first few postnatal days.”
The paper relies on this without support.
17-hydroxyprogesterone levels increase with time in infants affected with congenital adrenal hyperplasia.
“In contrast, 17-OHP levels increase with time in infants affected with CAH.”
The paper relies on this without support.
Premature, sick, or stressed infants typically have higher levels of 17-hydroxyprogesterone than term infants and generate many false positives unless higher cutoffs are used.
“Additionally, premature, sick, or stressed infants typically have higher levels of 17-OHP than term infants and generate many false positives unless higher cutoffs are used.”
The paper relies on this without support.
To obtain adequate sensitivity, cutoff levels for 17-hydroxyprogesterone are typically set low enough that approximately 1% of all tests are reported as positive.
“To obtain adequate sensitivity, the cutoff levels for 17-OHP are typically set low enough that approximately 1% of all tests are reported as positive.”
The paper relies on this without support.
Limitations of immunoassays for 17-hydroxyprogesterone include true elevations in levels in premature, sick, or stressed infants and lack of specificity of some antibodies for 17-hydroxyprogesterone.
“Limitations of immunoassays for 17-OHP include true elevations in levels in premature, sick, or stressed infants and lack of specificity of some antibodies for 17-OHP.”
The paper relies on this without support.
Immunoassay specificity can be increased by organic solvent extraction; this is currently mandated as a second screen in four states.
“Immunoassay specificity can be increased by organic solvent extraction; this is currently mandated as a second screen in four states.”
The paper relies on this without support.
CYP21A2 mutations can be detected in DNA extracted from the same dried blood spots that are used for hormonal screening.
“CYP21A2 mutations can be detected in DNA extracted from the same dried blood spots that are used for hormonal screening.”
The paper relies on this without support.
Genotyping is more costly than LC-MS/MS on a per-sample basis.
“Genotyping is more costly than LC-MS/MS on a per-sample basis.”
The paper relies on this without support.
Congenital adrenal hyperplasia is autosomal recessive; if a woman has previously had a child with congenital adrenal hyperplasia and again becomes pregnant via the same partner, her fetus will have a one in four chance of having congenital adrenal hyperplasia.
“CAH is autosomal recessive; if a woman has previously had a child with CAH and again becomes pregnant via the same partner, her fetus will have a one in four chance of having CAH.”
The paper relies on this without support.
Obtaining fetal DNA at chorionic villous biopsy reduces the length of time between instituting treatment and obtaining a genetic diagnosis.
“Obtaining fetal DNA at chorionic villous biopsy reduces the length of time between instituting treatment and obtaining a genetic diagnosis.”
The paper relies on this without support.
Knowing the specific mutations carried by each parent substantially increases the efficiency and speed of genetic diagnosis.
“Knowing the specific mutations carried by each parent substantially increases the efficiency and speed of genetic diagnosis.”
The paper relies on this without support.
Prescription of dexamethasone for prenatal treatment of congenital adrenal hyperplasia is an off-label use in the United States and European Union.
“Prescription of dexamethasone for prenatal treatment of CAH is an offlabel use in the United States and European Union.”
The paper relies on this without support.
The diagnosis of 21-hydroxylase deficiency is based on measuring 17-OHP and excluding 11-hydroxylase and P450 oxidoreductase deficiencies, in which 17-OHP may also be elevated.
“The diagnosis of 21-hydroxylase deficiency is based on measuring 17-OHP, the enzyme's principal substrate, and excluding 11-hydroxylase and P450 oxidoreductase deficiencies, in which 17-OHP may also be elevated.”
The paper relies on this without support.
Other steroids whose levels are usually elevated include 21-deoxycortisol, androstenedione, and testosterone.
“Other steroids whose levels are usually elevated include 21-deoxycortisol, androstenedione, and testosterone.”
The paper relies on this without support.
The severity of hormonal abnormalities depends on the degree of the enzymatic impairment, which depends on the genotype.
“The severity of hormonal abnormalities depends on the degree of the enzymatic impairment, which depends on the genotype.”
The paper relies on this without support.
A genetic test cannot detect salt wasting; this requires careful clinical evaluation.
“A genetic test cannot detect salt wasting; this requires careful clinical evaluation.”
The paper relies on this without support.
Compound heterozygotes for two different CYP21A2 mutations usually have a phenotype compatible with the milder mutation.
“Compound heterozygotes for two different CYP21A2 mutations usually have a phenotype compatible with the milder mutation.”
The paper relies on this without support.
Proper treatment with glucocorticoids prevents adrenal crisis and virilization, allowing normal growth and development.
“Proper treatment with GCs prevents adrenal crisis and virilization, allowing normal growth and development.”
The paper relies on this without support.
Undertreatment carries the risk of adrenal crisis and allows increased adrenal androgen production, with accelerated bone age and loss of growth potential; overtreatment may suppress growth, increase blood pressure, and cause iatrogenic Cushing's syndrome.
“Undertreatment carries the risk of adrenal crisis and allows increased adrenal androgen production, with accelerated bone age and loss of growth potential; overtreatment may suppress growth, increase blood pressure, and cause iatrogenic Cushing's syndrome.”
The paper relies on this without support.
Attempts to completely normalize 17-OHP levels typically result in overtreatment.
“Attempts to completely normalize 17-OHP levels typically result in overtreatment.”
The paper relies on this without support.
Infants with salt-wasting 21-hydroxylase deficiency require mineralocorticoids in addition to glucocorticoid treatment as well as supplemental sodium chloride.
“Infants with salt-wasting 21-hydroxylase deficiency require MCs in addition to GC treatment as well as supplemental sodium chloride.”
The paper relies on this without support.
The requirement for sodium in normally growing infants is approximately 1 mmol/kg per day, the amount provided by human milk.
“The requirement for sodium in normally growing infants is approximately 1 mmol/kg ⅐ d, the amount provided by human milk.”
The paper relies on this without support.
When pharmacological doses of hydrocortisone are given, mineralocorticoids are not needed because hydrocortisone can activate mineralocorticoid receptors.
“When pharmacological doses of HC are given, MCs are not needed because HC can activate MC receptors.”
The paper relies on this without support.
Either a reduced or an accelerated height velocity, signs of virilization, and delayed or premature bone maturation usually occur after protracted under- or overtreatment.
“Either a reduced or an accelerated height velocity, signs of virilization, and delayed or premature bone maturation usually occur after protracted under-or overtreatment.”
The paper relies on this without support.
17-OHP, androstenedione, and testosterone are the best indicators of the adequacy of glucocorticoid treatment.
“17-OHP, androstenedione, and testosterone are the best indicators of the adequacy of GC treatment.”
The paper relies on this without support.
Normal levels of 17-OHP and the other steroids are not a treatment goal but instead indicate overtreatment.
“Normal levels of 17-OHP and the other steroids are not a treatment goal but instead indicate overtreatment.”
The paper relies on this without support.
ACTH measurements are not useful for a diagnostic or therapeutic profile in CAH patients.
“ACTH measurements are not useful for a diagnostic or therapeutic profile in CAH patients.”
The paper relies on this without support.
Acceptably treated CAH patients generally have mildly elevated steroid levels when measured in a consistent manner, and dose adjustments should be made in the context of the overall clinical picture and not solely based on a single 17-OHP measurement.
“Acceptably treated CAH patients generally have mildly elevated steroid levels when measured in a consistent manner, and dose adjustments should be made in the context of the overall clinical picture and not solely based on a single 17-OHP measurement.”
The paper relies on this without support.
In adolescents with irregular menses and acne, symptoms are usually reversed within 3 months of glucocorticoid treatment, whereas remission of hirsutism is more difficult to achieve with glucocorticoid monotherapy.
“In adolescents with irregular menses and acne, symptoms are usually reversed within 3 months of GC treatment, whereas remission of hirsutism is more difficult to achieve with GC monotherapy.”
The paper relies on this without support.
Prolonged steroid therapy may reduce bone mineral density.
“Prolonged steroid therapy may reduce BMD.”
The paper relies on this without support.
The implied surgical advantage of delayed reconstruction is that the risk of vaginal stenosis and the need for subsequent dilation is diminished.
“The implied surgical advantage of delayed reconstruction is that the risk of vaginal stenosis and the need for subsequent dilation is diminished.”
The paper relies on this without support.
In infants with severe virilization where clitoroplasty is being considered, the advantages of early complete reconstruction are that the phallic skin can also be used as part of the vaginal reconstruction and gives the surgeon much more flexibility.
“In infants with severe virilization where clitoroplasty is being considered, the advantages of early complete reconstruction are that the phallic skin can also be used as part of the vaginal reconstruction and gives the surgeon much more flexibility.”
The paper relies on this without support.
Significant postoperative complications may occur after early or late surgery, such as urethra-vaginal fistulae and vaginal stenosis.
“Systematic long-term evaluation is lacking for both early and late surgery, for which significant postoperative complications may occur, such as urethra-vaginal fistulae and vaginal stenosis.”
The paper relies on this without support.
The incidence of urogenital sinus anomalies associated with CAH has not decreased.
“In contrast to other significant congenital abnormalities of the genitourinary system (bladder exstrophy, prune belly syndrome, and posterior urethral valves), the incidence of urogenital sinus anomalies associated with CAH has not decreased.”
The paper relies on this without support.
The adult short stature of many CAH patients may be caused by hypercortisolism, hyperandrogenism, or both.
“The adult short stature of many CAH patients may be caused by hypercortisolism, hyperandrogenism, or both.”
The paper relies on this without support.
Patients with NCCAH can also have compromised adult height, but height deficit is less severe than with classic CAH.
“Patients with NCCAH can also have compromised adult height, but height deficit is less severe than with classic CAH.”
The paper relies on this without support.
Normal adult height can be achieved in CAH with judicious use of standard glucocorticoid and mineralocorticoid therapies.
“Normal adult height can be achieved in CAH with judicious use of standard GC and MC therapies, and height-enhancing drugs are not recommended for individuals whose height is, or is expected to be, more than Ϫ2.25 SD.”
The paper relies on this without support.
Bilateral adrenalectomy reduces the risk of virilization in females and allows for treatment with lower glucocorticoid doses.
“Bilateral adrenalectomy reduces the risk of virilization in females and allows for treatment with lower GC doses.”
The paper relies on this without support.
Objections to adrenalectomy are based on surgical risk, possible increased risk of adrenal crisis due to loss of protective residual adrenal function, and possible loss of hormones that may have beneficial effects such as epinephrine and DHEA.
“Objections to adrenalectomy are based on surgical risk, possible increased risk of adrenal crisis due to loss of protective residual adrenal function, and possible loss of hormones that may have beneficial effects such as epinephrine and DHEA.”
The paper relies on this without support.
Individuals with a history of noncompliance are poor candidates for adrenalectomy because postoperative noncompliance in an adrenalectomized patient could be fatal.
“Individuals with a history of noncompliance are poor candidates for adrenalectomy because postoperative noncompliance in an adrenalectomized patient could be fatal.”
The paper relies on this without support.
Existing glucocorticoid therapy is nonphysiological and may contribute to adverse outcomes.
“Existing GC therapy is nonphysiological and may contribute to adverse outcomes.”
The paper relies on this without support.
The clinical implications of epinephrine deficiency are not fully known, but it likely plays a role in the risk for hypoglycemia during febrile illnesses, especially in young children.
“The clinical implications of epinephrine deficiency are not fully known, but it likely plays a role in the risk for hypoglycemia during febrile illnesses, especially in young children.”
The paper relies on this without support.
Current GC therapy for CAH is suboptimal because supraphysiological doses are often needed to suppress adrenal androgens.
“Current GC therapy for CAH is suboptimal because supraphysiological doses are often needed to suppress adrenal androgens.”
The paper relies on this without support.
Excess GC places patients at risk for iatrogenic Cushing's syndrome.
“Excess GC places patients at risk for iatrogenic Cushing's syndrome, and lower-dose GC leads to inadequately treated androgen excess.”
The paper relies on this without support.
Lower-dose GC leads to inadequately treated androgen excess.
“Excess GC places patients at risk for iatrogenic Cushing's syndrome, and lower-dose GC leads to inadequately treated androgen excess.”
The paper relies on this without support.
NCCAH patients reach higher than 1000 ng/dl (33 nmol/liter) after ACTH stimulation.
“ACTH stimulation is needed for patients with baseline 17-OHP around the cutoff; NCCAH patients reach higher than 1000 ng/dl (33 nmol/ liter).”
The paper relies on this without support.
Testicular adrenal rest tumors are common in adults with classic CAH but seem to be rare in NCCAH.
“Testicular adrenal rest tumors are common in adults with classic CAH but seem to be rare in NCCAH.”
The paper relies on this without support.
Adults with classic CAH are treated to avoid symptoms of adrenocortical deficiency in both sexes; hyperandrogenism, voice changes, and infertility in women; and testicular tumors in men.
“Adults with classic CAH are treated to avoid symptoms of adrenocortical deficiency in both sexes; hyperandrogenism, voice changes, and infertility in women; and testicular tumors in men.”
The paper relies on this without support.
Overtreatment with GCs will cause Cushingoid features, and excess MCs will cause hypertension.
“However, overtreatment with GCs will cause Cushingoid features, and excess MCs will cause hypertension.”
The paper relies on this without support.
GC substitution in the adult CAH patient aims to suppress virilization and menstrual disturbance in women, alteration of gonadotropin secretion in both sexes, and testicular adrenal rest tumors in men.
“GC substitution in the adult CAH patient aims to suppress virilization and menstrual disturbance in women, alteration of gonadotropin secretion in both sexes, and testicular adrenal rest tumors in men.”
The paper relies on this without support.
GC overtreatment may cause Cushingoid symptoms, whereas undertreatment may cause Addisonian symptoms.
“GC overtreatment may cause Cushingoid symptoms, whereas undertreatment may cause Addisonian symptoms.”
The paper relies on this without support.
Overtreatment with MCs may cause hypertension; undertreatment may lead to low blood pressure, salt loss, fatigue, and increased requirements for GC replacement.
“Overtreatment with MCs may cause hypertension; undertreatment may lead to low blood pressure, salt loss, fatigue, and increased requirements for GC replacement.”
The paper relies on this without support.
The principles of monitoring GC treatment in adult CAH patients are similar to those employed in monitoring children.
“The principles of monitoring GC treatment in adult CAH patients are similar to those employed in monitoring children.”
The paper relies on this without support.
Testosterone levels in men normally reflect gonadal rather than adrenal function and therefore are not useful for monitoring therapy.
“Optimal levels for 17-OHP and androstenedione have not been defined; testosterone levels in men normally reflect gonadal rather than adrenal function and therefore are not useful for monitoring therapy.”
The paper relies on this without support.
17-OHP may be elevated at night, even when morning levels are acceptable.
“17-OHP may be elevated at night, even when morning levels are acceptable.”
The paper relies on this without support.
Women with CAH are often overweight, with high blood pressure and hyperinsulinemia, and have risk factors for cardiovascular disease.
“Women with CAH are often overweight, with high blood pressure and hyperinsulinemia, and have risk factors for cardiovascular disease.”
The paper relies on this without support.
CAH is autosomal recessive.
“CAH is autosomal recessive.”
The paper relies on this without support.
The genotype and phenotype correlate well; siblings with CAH generally, but not always, have similar symptoms and degrees of female virilization.
“The genotype and phenotype correlate well; siblings with CAH generally, but not always, have similar symptoms and degrees of female virilization.”
The paper relies on this without support.
For NCCAH, about two thirds of patients are compound heterozygotes, carrying one allele that causes classic CAH and one that causes NCCAH.
“For NCCAH, about two thirds of patients are compound heterozygotes, carrying one allele that causes classic CAH and one that causes NCCAH.”
The paper relies on this without support.
Adult women with CAH often remember childhood visits to their physician as highly intrusive.
“Adult women with CAH often remember childhood visits to their physician as highly intrusive.”
The paper relies on this without support.
Pediatric endocrine care is usually transferred to an adult endocrinologist at the end of adolescence, usually coinciding with the completion of secondary school, i.e. typically at age 18.
“Pediatric endocrine care is usually transferred to an adult endocrinologist at the end of adolescence, usually coinciding with the completion of secondary school, i.e. typically at age 18.”
The paper relies on this without support.
Testicular adrenal rest tumors increase with age in CAH, impairing fertility.
“Testicular adrenal rest tumors increase with age in CAH, impairing fertility.”
The paper relies on this without support.
Undetected adrenal rest tumors may obstruct the seminiferous tubules, causing secondary gonadal dysfunction and infertility.
“Undetected adrenal rest tumors may obstruct the seminiferous tubules, causing secondary go-nadal dysfunction and infertility.”
The paper relies on this without support.
Higher binding globulins and placental aromatization typically protect the fetus from the potential virilizing effects of maternal androgens.
“However, higher binding globulins and placental aromatization typically protect the fetus from the potential virilizing effects of maternal androgens.”
The paper relies on this without support.
Maternal 17-OHP is elevated in normal pregnancy and hence cannot be used to monitor GC treatment.
“Maternal 17-OHP is elevated in normal pregnancy and hence cannot be used to monitor GC treatment.”
The paper relies on this without support.
Symptoms of adrenal insufficiency, including postural hypotension, may rarely develop in pregnant women with classic CAH.
“Symptoms of adrenal insufficiency, including postural hypotension, may rarely develop in pregnant women with classic CAH.”
The paper relies on this without support.
Patients with CAH may experience psychosocial and psychiatric problems that are not specific to CAH.
“Patients with CAH may experience psychosocial and psychiatric problems that are not specific to CAH.”
The paper relies on this without support.
These can usually be managed by standard mental health clinicians.
“These can usually be managed by standard mental health clinicians.”
The paper relies on this without support.
The 46,XX patients with CAH may also have to cope with problems that are more specific to DSD, such as parent/family medical education, gender assignment, decisions on genital surgery, and referral for psychological gender evaluation.
“The 46,XX patients with CAH may also have to cope with problems that are more specific to DSD, such as 1) parent/family medical education, parent/family counseling regarding psychosocial prognosis, and managing parents' distress; 2) gender assignment at birth in cases of marked genital virilization; 3) decisions on gender-confirming (not medically necessitated) genital surgery in infancy and early”
The paper relies on this without support.
Apart from urinary tract malformations in a minority of CAH girls, genital ambiguity usually does not require urgent surgical intervention.
“Apart from urinary tract malformations in a minority of CAH girls, genital ambiguity usually does not require urgent surgical intervention.”
The paper relies on this without support.
Severely virilized cases may initially be assigned as males, and once such assignment has been made, it may be difficult to reverse, thereby sacrificing fertility.
“Severely virilized cases may initially be assigned as males, and once such assignment has been made, it may be difficult to reverse, thereby sacrificing fertility.”
The paper relies on this without support.
In markedly virilized female-raised children, surgical intervention can facilitate heterosexual intercourse and conception, if desired.
“In markedly virilized female-raised children, surgical intervention can facilitate heterosexual intercourse and conception, if desired.”
The paper relies on this without support.
Fertility and fecundity, although reduced, remain feasible.
“Fertility and fecundity, although reduced, remain feasible.”
The paper relies on this without support.
Because the fetal adrenal has low levels of 3β-HSD, most steroidogenesis is directed toward DHEA, but small amounts of steroid enter the pathways toward aldosterone and cortisol.
“Because the fetal adrenal has low levels of 3-HSD, most steroidogenesis is directed toward DHEA (and thence to DHEA-sulfate), but small amounts of steroid enter the pathways toward aldosterone and cortisol.”
The paper relies on this without support.
The adrenal 21-hydroxylase, P450c21, is essential in both pathways.
“The adrenal 21-hydroxylase, P450c21, is essential in both pathways.”
The paper relies on this without support.
The adrenal can make small amounts of testosterone via 17β-HSD.
“The adrenal can make small amounts of testosterone via 17-HSD.”
The paper relies on this without support.
In the absence of the 21-hydroxylase activity of P450c21, three pathways lead to androgens.
“In the absence of the 21-hydroxylase activity of P450c21, three pathways lead to androgens.”
The paper relies on this without support.
Randomly measured 17-OHP levels can be normal in NCCAH; hence, a screening 17-OHP level should be measured in the early morning (before 0800 h).
“Note that randomly measured 17-OHP levels can be normal in NCCAH; hence, a screening 17-OHP level should be measured in the early morning (before 0800 h).”
The paper relies on this without support.
Steroid measurements may differ with the assay employed.
“Steroid measurements may differ with the assay employed.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CAH due to 21-hydroxylase deficiency is the most common cause of adrenal insufficiency in infancy.
“CAH due to 21-hydroxylase deficiency is the most common cause of adrenal insufficiency in infancy (14).”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [14]
The Definition, Pathophysiology, and Morbidities section says 21-hydroxylase deficiency accounts for approximately 95% of CAH and describes cortisol deficiency and potentially fatal salt loss in newborns. The 1.3 Remarks section also discusses adrenal insufficiency in infants with positive CAH screens. Neither passage establishes that it is the most common cause of adrenal insufficiency in infancy relative to other causes. (LLM, conf=0.82)
Experimental — accuracy not yet measuredA 17-OHprogesterone level >1000 ng/dL is diagnostic for 21-OH deficiency.
“a 17-OHprogesterone Ͼ1000 ng/dL is diagnostic for 21-OH deficiency (14).”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [14]
The guideline’s 9.1 Evidence section says that patients with nonclassical congenital adrenal hyperplasia reach 17-OHP levels above 1000 ng/dL after ACTH stimulation. It does not say that any 17-OHP result above that threshold is diagnostic of 21-hydroxylase deficiency; the 3.1–3.3 Evidence section notes that other enzyme deficiencies can also elevate 17-OHP. (LLM, conf=0.88)
Experimental — accuracy not yet measured21-Hydroxylase deficiency, caused by mutations in P450c21, is the most common form of CAH and one of the most common inborn errors of metabolism.
“21-Hydroxylase deficiency, caused by mutations in P450c21, is the most common form of CAH and one of the most common inborn errors of metabolism.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [410]
The Definition, Pathophysiology, and Morbidities section says that mutations in CYP21A2, the gene encoding P450c21, cause the most common form of CAH, accounting for approximately 95% of cases. The guideline calls CAH common in its newborn-screening evidence section, but does not establish that it is one of the most common inborn errors of metabolism. No page numbers are available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measuredAfter appropriate fluid resuscitation, mineralocorticoids and glucocorticoids can be replaced orally, and ambiguous genitalia can be corrected with plastic surgery, but management is complicated and difficult.
“After appropriate fluid resuscitation, the mineralocorticoids and glucocorticoids can be replaced orally, and the ambiguous genitalia can be corrected with a series of plastic surgical procedures, but the management is complicated and difficult (408, 410).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [410]
The maintenance-therapy tables list glucocorticoid and fludrocortisone tablets, and the feminizing-surgery recommendation describes genital reconstruction for severely virilized patients (sections 7.0 and Supplemental Information; pages not provided). The guideline also says surgical decisions are difficult (section 7.3 Remarks). It does not establish the claimed sequence after fluid resuscitation or that surgery reliably corrects ambiguous genitalia; its discussion of surgical outcomes notes complications and variable results. (LLM, conf=0.84)
Experimental — accuracy not yet measuredAdditional challenges in the management of 21OHD derive from the uncertainties surrounding the optimal use of biomarkers to assess disease control.
“Additional challenges in the management of 21OHD derive from the uncertainties surrounding the optimal use of biomarkers to assess disease control (10, 11).”
From 24-Hour Profiles of 11-Oxygenated C19 Steroids and Δ5-Steroid Sulfates during Oral and Continuous Subcutaneous Glucocorticoids in 21-Hydroxylase Deficiency (2021) · cites this paper as [10]
On average, 8 pregnancies at risk for CAH must be treated for every affected female who might benefit from prenatal dexamethasone treatment.
“Risk-benefit assessments must consider that, on average, 8 pregnancies at risk for CAH must be treated for every affected female who might benefit from the treatment (443-446).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [445]
The reported prevalence for nonclassic congenital adrenal hyperplasia is 1 in 1,000, with increased prevalence in specific ethnic groups.
“The reported prevalence for NCAH is 1 in 1,000 with an increased prevalence in specific ethnic groups [99]”
From The Diagnosis of Polycystic Ovary Syndrome during Adolescence (2015) · cites this paper as [99]
The incidence of classic CAH ranges from 1 in 10,000 to 20,000 live births worldwide.
“The incidence of classic CAH ranges from 1 in 10,000 to 20,000 live births worldwide and is subclassified into salt-wasting (SW) and simple virilizing (SV), reflecting the degree of aldosterone deficiency (2).”
From Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia (2012) · cites this paper as [2]
By consensus, hydrocortisone is the treatment of choice for children with CAH.
“By consensus, hydrocortisone is the treatment of choice for children (2), but several glucocorticoid preparations are used for adults (4).”
From Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia (2012) · cites this paper as [2]
Classic CAH is subclassified into salt-wasting (SW) and simple virilizing (SV), reflecting the degree of aldosterone deficiency.
“The incidence of classic CAH ranges from 1 in 10,000 to 20,000 live births worldwide and is subclassified into salt-wasting (SW) and simple virilizing (SV), reflecting the degree of aldosterone deficiency (2).”
From Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia (2012) · cites this paper as [2]
Teratogenic effects of Dex observed in animal models include renal dysgenesis, reduced pancreatic beta cell numbers, impaired glucose tolerance, and increased systolic and diastolic blood pressure.
“Teratogenic effects of Dex observed in animal models include renal dysgenesis, reduced pancreatic b cell numbers, impaired glucose tolerance, and increased systolic and diastolic blood pressure, all discussed previously (1).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [1]
Guidance for replacement glucocorticoids in children is to use the lowest possible dose and to use hydrocortisone rather than synthetic steroids such as prednisolone and dexamethasone, which have a greater suppressive effect on growth.
“Guidance for use of replacement glucocorticoids in children is to use the lowest possible dose, and to use the native hormone, hydrocortisone (cortisol), rather than synthetic steroids such as prednisolone and dexamethasone which have a greater suppressive effect on growth (4).”
From Immediate-release granule formulation of hydrocortisone, Alkindi®, for treatment of paediatric adrenal insufficiency (Infacort development programme) (2018) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Adrenalectomy patient subgroups total 19, not 18
MinorThe four listed subgroups contain 14 + 2 + 1 + 2 = 19 patients, one more than the stated total of 18.
Reported 18 · recomputed 19
“Van Wyk and Ritzen (202) reported follow-up of 18 patients with CAH (14 salt-wasting, two simple virilizing, one nonclassic, and two 11-hydroxylase deficiency) from 11 centers who underwent bilateral adrenalectomy (13 laparoscopic and five open flank).”
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681 · see citing works
Abiraterone and Increased Survival in Metastatic Prostate Cancer
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407 · see citing works
WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASE
Barker, D. J. P., Osmond, C., Winter, P. D., Margetts, B., & Simmonds, S. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90710-1 · Cited by 3,574 · see citing works
Presence of fetal DNA in maternal plasma and serum
Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02174-0 · Cited by 3,129 · see citing works
Consensus Statement on Management of Intersex Disorders
Lee, P. A., Houk, C. P., Ahmed, S. F., Hughes, I. A., & in collaboration with the participants in the International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology (2006) · Pediatrics · doi:10.1542/peds.2006-0738 · Cited by 2,324 · see citing works
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946 · see citing works
In utero programming of chronic disease
BARKER, D. J. P. (1998) · Clinical Science · doi:10.1042/cs0950115 · Cited by 1,765 · see citing works
Fetal and placental size and risk of hypertension in adult life.
Barker, D. J., Bull, A. R., Osmond, C., & Simmonds, S. J. (1990) · BMJ · doi:10.1136/bmj.301.6746.259 · Cited by 1,728 · see citing works
Lo, Y. M. D., Tein, M., Lau, T. K., Haines, C. J., Leung, T. N., Poon, P. M. K., Wainscoat, J. S., Johnson, P. J., Chang, A. M. Z., & Hjelm, N. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301800 · Cited by 1,645 · see citing works
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432 · see citing works
Self-citationCongenital Adrenal Hyperplasia
Speiser, P., & White, P. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409 · see citing works
Self-citationCongenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Self-citationTwenty-four hour pattern of the episodic secretion of cortisol in normal subjects
WEITZMAN, E. D., FUKUSHIMA, D., NOGEIRE, C., ROFFWARG, H., GALLAGHER, T. F., & HELLMAN, L. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-1-14 · Cited by 1,258 · see citing works
Glucocorticoids, prenatal stress and the programming of disease
Harris, A., & Seckl, J. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.06.007 · Cited by 871 · see citing works
Incidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869 · see citing works
Glucocorticoid exposure in utero: new model for adult hypertension
Benediktsson, R., Lindsay, R. S., Noble, J., Seckl, J. R., & Edwards, C. R. W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90138-7 · Cited by 862 · see citing works
Prenatal glucocorticoids and long-term programming
Seckl (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u049 · Cited by 825 · see citing works
Consensus statement on management of intersex disorders
Hughes, I. A., Houk, C., Ahmed, S. F., & Lee, P. A. (2006) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2006.03.004 · Cited by 684 · see citing works
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642 · see citing works
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628 · see citing works
Self-citationGenotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624 · see citing works
Self-citationMaternal Cigarette Smoking, Metabolic Gene Polymorphism, and Infant Birth Weight
Wang, X. (2002) · JAMA · doi:10.1001/jama.287.2.195 · Cited by 612 · see citing works
Patterns of gender development
Martin, C. L., & Ruble, D. N. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100511 · Cited by 600 · see citing works
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572 · see citing works
Self-citationHigh frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523 · see citing works
Self-citation11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517 · see citing works
Self-citationMartin, K. A., Chang, R. J., Ehrmann, D. A., Ibáñez, L., Løbo, R. A., Rosenfield, R. L., Shapiro, J., Montori, V. M., & Swiglo, B. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2437 · Cited by 506 · see citing works
Self-citationHealth status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506 · see citing works
Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus
Uno, H., Lohmiller, L., Thieme, C. S., Kemnitz, J. W., Engle, M. J., Roecker, E. B., & Farrell, P. M. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90002-g · Cited by 503 · see citing works
Watson, M. S., Mann, M. Y., Lloyd-Puryear, M. A., Rinaldo, P., & Howell, R. R. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000223891.82390.ad · Cited by 492 · see citing works
Dalziel, S. R., Walker, N. K., Parag, V., Mantell, C., Rea, H. H., Rodgers, A., & Harding, J. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66617-2 · Cited by 461 · see citing works
Vogeser, M., Zachoval, R., Felbinger, T. W., Jacob, K., Radetti, G., Bona, G., Corrias, A., Cappa, M., DeSanctis, V., Lauriola, S., et al. (2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 451 · see citing works
Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia
Dessens, A. B., Slijper, F. M. E., & Drop, S. L. S. (2005) · Archives of Sexual Behavior · doi:10.1007/s10508-005-4338-5 · Cited by 425 · see citing works
Carmina, E., Rosato, F., Jannì, A., Rizzo, M., & Longo, R. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1457 · Cited by 420 · see citing works
Krone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397 · see citing works
Maternal prenatal cortisol and infant cognitive development: moderation by infant–mother attachment
Bergman, K., Sarkar, P., Glover, V., & O'Connor, T. G. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.002 · Cited by 395 · see citing works
Pang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392 · see citing works
Murphy, K. E., Hannah, M. E., Willan, A. R., Hewson, S. A., Ohlsson, A., Kelly, E. N., Matthews, S. G., Saigal, S., Asztalos, E., Ross, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61929-7 · Cited by 391 · see citing works
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370 · see citing works
Fraser, F. C., & Fainstat, T. (1951) · PubMed · Cited by 357 · see citing works
Therrell, B. L., Berenbaum, S. A., Manter-Kapanke, V., Simmank, J., Korman, K., Prentice, L., Gonzalez, J., & Gunn, S. (1998) · Pediatrics · doi:10.1542/peds.101.4.583 · Cited by 344 · see citing works
Total urogenital mobilization–an easier way to repair cloacas
Peña, A. (1997) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(97)90191-3 · Cited by 343 · see citing works
Long-term outcomes after repeat doses of antenatal corticosteroids
Wapner, R. J., Sorokin, Y., Mele, L., Johnson, F., Dudley, D. J., Spong, C. Y., Peaceman, A. M., Leveno, K. J., Malone, F., Caritis, S. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071453 · Cited by 336 · see citing works
Meyer-Bahlburg, H. F. L., Dolezal, C., Baker, S. W., & New, M. I. (2008) · Archives of Sexual Behavior · doi:10.1007/s10508-007-9265-1 · Cited by 326 · see citing works
Self-citationSteroid 21-hydroxylase deficiency: genotype may not predict phenotype
Wilson, R. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.8.2322 · Cited by 324 · see citing works
Modified-release hydrocortisone to provide circadian cortisol profiles
Debono, M., Ghobadi, C., Rostami-Hodjegan, A., Huatan, H., Campbell, M. J., Newell-Price, J., Darzy, K., Merke, D. P., Arlt, W., & Ross, R. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2380 · Cited by 322 · see citing works
Self-citationMinto, C. L., Liao, L., Woodhouse, C. R. J., Ransley, P. G., & Creighton, S. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12980-7 · Cited by 319 · see citing works
Nonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315 · see citing works
WEBSTER, E. L., Lewis, D. B., Torpy, D. J., Zachman, E. K., Rice, K. C., & Chrousos, G. P. (1996) · Endocrinology · doi:10.1210/endo.137.12.8940412 · Cited by 312 · see citing works
Diamond, M. (1997) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1997.02170470080015 · Cited by 308 · see citing works
Stikkelbroeck, N. M. M. L., Otten, B. J., Pasic, A., Jager, G. J., Sweep, C. G. J. F., Noordam, K., & Hermus, A. R. M. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8090 · Cited by 305 · see citing works
Barnes, R. B., Rosenfield, R. L., Ehrmann, D. A., Cara, J. F., Cuttler, L., Levitsky, L. L., & Rosenthal, I. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962325 · Cited by 304 · see citing works
Pang, S., Wallace, M. A., Hofman, L. F., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · PEDIATRICS · doi:10.1542/peds.81.6.866 · Cited by 302 · see citing works
Swiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302 · see citing works
Self-citationMaternal corticosteroid use and orofacial clefts
Carmichael, S. L., Shaw, G. M., Ma, C., Werler, M. M., Rasmussen, S. A., & Lammer, E. J. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.05.046 · Cited by 301 · see citing works
PANG, S., HOTCHKISS, J., DRASH, A. L., LEVINE, L. S., & NEW, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-1003 · Cited by 293 · see citing works
White, P. C., New, M. I., & Dupont, B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.23.7505 · Cited by 292 · see citing works
Self-citationU.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00008 · Cited by 291 · see citing works
In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development
Goto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25091 · Cited by 284 · see citing works
Effect of corticosteroids on brain growth in fetal sheep.
Huang, W.-L., Beazley, L., Quinlivan, J., Evans, S., Newnham, J., & Dunlop, S. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00265-3 · Cited by 280 · see citing works
Frisén, L., Nordenström, A., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., Möller, A., & Nordenskjöld, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0636 · Cited by 276 · see citing works
Clinical review 56: Nonclassic adrenal hyperplasia: current concepts
Azziz, R., Dewailly, D., & Owerbach, D. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.4.8157702 · Cited by 275 · see citing works
Self-citationAdrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency.
Merke, D. P., Chrousos, G. P., Eisenhofer, G., Weise, M., Keil, M. F., Rogol, A. D., Van Wyk, J. J., & Bornstein, S. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431903 · Cited by 266 · see citing works
Self-citationHigh frequency of nonclassical steroid 21-hydroxylase deficiency.
Speiser, P., Dupont, B., Rubinstein, P., Piazza, A., Kaštelan, A., & New, M. I. (1985) · PubMed · Cited by 265 · see citing works
Self-citationNew, M. I., Carlson, A., Obeid, J., Marshall, I., Cabrera, M. S., Goseco, A., Lin-Su, K., Putnam, A. S., Wei, J. Q., & Wilson, R. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8072 · Cited by 263 · see citing works
Maternal corticosteroid use and risk of selected congenital anomalies
Carmichael, S. L., & Shaw, G. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990917)86:3 · Cited by 262 · see citing works
Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency
David, M., & Forest, M. G. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80310-8 · Cited by 258 · see citing works
Tusie-Luna, M. T., Traktman, P., & White, P. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45304-x · Cited by 254 · see citing works
Self-citationCrouch, N. S., Liao, L. M., Woodhouse, C. R. J., Conway, G. S., & Creighton, S. M. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.09.079 · Cited by 249 · see citing works
Azziz, R., Hincapie, L. A., Knochenhauer, E. S., Dewailly, D., Fox, L., & Boots, L. R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00383-0 · Cited by 244 · see citing works
Self-citationOelkers, W. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5939-1 · Cited by 243 · see citing works
Neonatal screening for congenital adrenal hyperplasia
White, P. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.148 · Cited by 240 · see citing works
Self-citationANATOMICAL STUDIES OF THE HUMAN CLITORIS
Baskin, L. S., Erol, A., LI, Y. W., LIU, W. H., Kurzrock, E. A., & Cunha, G. R. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)68052-2 · Cited by 240 · see citing works
Self-citationCelsi, G., Kistner, A., Aizman, R., EklÖF, A.-C., Ceccatelli, S., De Santiago, A., & Jacobson, S. H. (1998) · Pediatric Research · doi:10.1203/00006450-199809000-00009 · Cited by 239 · see citing works
Berenbaum, S. A., & Bailey, J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020782 · Cited by 238 · see citing works
de Vries, A., Holmes, M. C., Heijnis, A., Seier, J. V., van Heerden, J., Louw, J., Wolfe‐Coote, S. A., Meaney, M. J., Levitt, N. S., & Seckl, J. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30982 · Cited by 238 · see citing works
Population-based case-control study of teratogenic potential of corticosteroids.
Czeizel, A., & Rockenbauer, M. (1997) · Teratology · doi:10.1002/(sici)1096-9926(199711)56:5 · Cited by 235 · see citing works
Gender development in women with congenital adrenal hyperplasia as a function of disorder severity
Meyer-Bahlburg, H. F. L., Dolezal, C., Baker, S. W., Ehrhardt, A. A., & New, M. I. (2006) · Archives of Sexual Behavior · doi:10.1007/s10508-006-9068-9 · Cited by 234 · see citing works
Self-citationTransgenderism and Intersexuality in Childhood and Adolescence: Making Choices
Cohen-Kettenis, P., & Pfäfflin, F. (2003) · doi:10.4135/9781452233628 · Cited by 231 · see citing works
Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.
Jaresch, S., Kornely, E., Kley, H. K., & Schlaghecke, R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1311000 · Cited by 227 · see citing works
Hirvikoski, T., Nordenström, A., Lindholm, T., Lindblad, F., Ritzén, E. M., Wedell, A., & Lajić, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1340 · Cited by 224 · see citing works
Expanded Newborn Screening for Biochemical Disorders: The Effect of a False-Positive Result
Gurian, E. A., Kinnamon, D. D., Henry, J. J., & Waisbren, S. E. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2294 · Cited by 223 · see citing works
Newborn screening for congenital adrenal hyperplasia
Therrell, B. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70017-3 · Cited by 221 · see citing works
Matern, D., Tortorelli, S., Oglesbee, D., Gavrilov, D., & Rinaldo, P. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0691-y · Cited by 217 · see citing works
Trautman, P. D., Meyer-Bahlburg, H. F. L., Postelnek, J., & New, M. I. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)00070-0 · Cited by 217 · see citing works
Self-citationLacey, J. M., Minutti, C. Z., Magera, M. J., Tauscher, A. L., Casetta, B., McCann, M., Lymp, J., Hahn, S. H., Rinaldo, P., & Matern, D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.027193 · Cited by 216 · cited 2× · see citing works
“Assays of sufficient sensitivity such as immunoassays after extraction and chromatography, or LC/MS-MS, should be used in conjunction with appropriate reference data (42, 141).”
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Tardy, V., Billaud, L., Laborde, K., Coussieu, C., Morel, Y., Vaury, C., Golmard, J.-L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1582 · Cited by 213 · see citing works
Janzen, N., Peter, M., Sander, S., Steuerwald, U., Terhardt, M., Holtkamp, U., & Sander, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2890 · Cited by 211 · see citing works
Nordenskjöld, A., Holmdahl, G., Frisén, L., Falhammar, H., Filipsson, H., Thorén, M., Janson, P. O., & Hagenfeldt, K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0556 · Cited by 205 · see citing works
Hagenfeldt, K., Janson, P. O., Holmdahl, G., Falhammar, H., Filipsson, H., Frisen, L., Thoren, M., & Nordenskjold, A. (2008) · Human Reproduction · doi:10.1093/humrep/den118 · Cited by 205 · see citing works
Long Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia1
Cabrera, M. S., Vogiatzi, M. G., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7668 · Cited by 204 · see citing works
Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Golmard, J.-L., Tardy, V., Morel, Y., Clauin, S., Coussieu, C., Boudou, P., Mowzowicz, I., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1383 · Cited by 204 · see citing works
Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia
KOHN, B., LEVINE, L. S., POLLACK, M. S., PANG, S., LORENZEN, F., LEVY, D., LERNER, A. J., RONDANINI, G. F., DUPONT, B., & NEW, M. I. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-5-817 · Cited by 204 · see citing works
Forest, M. G. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh047 · Cited by 200 · see citing works
Adult Height and Fertility in Men with Congenital Virilizing Adrenal Hyperplasia
Urban, M. D., Lee, P. A., & Migeon, C. J. (1978) · New England Journal of Medicine · doi:10.1056/nejm197812212992505 · Cited by 198 · see citing works
Eugster, E. A., DiMeglio, L. A., Wright, J. C., Freidenberg, G. R., SESHADRI, R. M., & Pescovitz, O. H. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.110527 · Cited by 193 · see citing works
Finkielstain, G. P., Chen, W., Mehta, S. P., Fujimura, F. K., Hanna, R. M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0319 · Cited by 192 · see citing works
Self-citationKamrath, C., Hochberg, Z., Hartmann, M. F., Remer, T., & Wudy, S. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1997 · Cited by 191 · see citing works
Merke, D. P., Keil, M. F., Jones, J. V., Fields, J., Hill, S., & Cutler, G. B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6462 · Cited by 190 · see citing works
Self-citationCasteràs, A., De Silva, P., Rumsby, G., & Conway, G. S. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03563.x · Cited by 190 · see citing works
Safari, H. R., Fassett, M. J., Souter, I. C., Alsulyman, O. M., & Goodwin, T. M. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70189-9 · Cited by 187 · see citing works
Yang, Z., Mendoza, A. R., Welch, T. R., Zipf, W. B., & Yu, C. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12147 · Cited by 184 · see citing works
Völkl, T. M. K., Simm, D., Beier, C., & Dörr, H. G. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1005 · Cited by 184 · see citing works
Adult Height in Patients with Congenital Adrenal Hyperplasia: A Systematic Review and Metaanalysis
Muthusamy, K., Elamin, M. B., Smushkin, G., Murad, M. H., Lampropulos, J. F., Elamin, K. B., Abu Elnour, N. O., Gallegos-Orozco, J. F., Fatourechi, M. M., Agrwal, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2616 · Cited by 182 · see citing works
Self-citationEscobar-Morreale, H. F., Sánchón, R., & Millán, J. L. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2053 · Cited by 179 · see citing works
Rijnders, R. J. P., van der Schoot, C. E., Bossers, B., de Vroede, M. A. M. J., & Christiaens, G. C. M. L. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01480-6 · Cited by 175 · see citing works
Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia
Moran, C., Azziz, R., Weintrob, N., Witchel, S. F., Rohmer, V., Dewailly, D., Marcondes, J. A. M., Pugeat, M., Speiser, P. W., Pignatelli, D., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0062 · Cited by 174 · see citing works
Self-citationQuality of life in 70 women with disorders of sex development
Johannsen, T. H., Ripa, C. P. L., Mortensen, E. L., & Main, K. M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02294 · Cited by 171 · see citing works
High prevalence of reduced fecundity in men with congenital adrenal hyperplasia
Reisch, N., Flade, L., Scherr, M., Rottenkolber, M., Pedrosa Gil, F., Bidlingmaier, M., Wolff, H., Schwarz, H.-P., Quinkler, M., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1414 · Cited by 170 · cited 1× · see citing works
“Fertility may be impaired by suppression of gonadotropin secretion by adrenal steroids if adequate doses of GCs are not given (242).”
Rauh, M., Gröschl, M., Rascher, W., & Dörr, H. G. (2006) · Steroids · doi:10.1016/j.steroids.2006.01.015 · Cited by 170 · see citing works
Falhammar, H., Nyström, H. F., Ekström, U., Granberg, S., Wedell, A., & Thorén, M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0828 · Cited by 170 · see citing works
Non-invasive prenatal determination of fetal sex: translating research into clinical practice
Hill, M., Finning, K., Martin, P., Hogg, J., Meaney, C., Norbury, G., Daniels, G., & Chitty, L. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01533.x · Cited by 168 · see citing works
Prenatal diagnosis and treatment of 21-hydroxylase deficiency
Forest, M. G., David, M., & Morel, Y. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90125-g · Cited by 167 · see citing works
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167 · see citing works
Bonfig, W., Bechtold, S., Schmidt, H., Knorr, D., & Schwarz, H. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2109 · Cited by 167 · see citing works
Clinical review 54: genetics, diagnosis, and management of 21-hydroxylase deficiency
Miller, W. L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.241 · Cited by 167 · see citing works
Comprehensive cost-utility analysis of newborn screening strategies
Carroll, A. E., & Downs, S. M. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2633h · Cited by 165 · see citing works
Lajic, S., Wedell, A., Bui, T.-H., Ritzén, E. M., & Holst, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5233 · Cited by 164 · see citing works
A Long-term Outcome Study of Intersex Conditions
Warne, G. L., Grover, S. R., Hutson, J., Sinclair, A. H., Metcalfe, S. A., NORTHAM, E. A., Freeman, J. L., & Institut, M. C. R. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.6.555 · Cited by 163 · see citing works
Subtle cognitive impairments in patients with long-term cure of Cushing’s disease
Tiemensma, J., Kokshoorn, N. E., Biermasz, N. R., Keijser, B.-J. S. A., Wassenaar, M. J. E., Middelkoop, H. A. M., Pereira, A. M., & Romijn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2032 · Cited by 159 · see citing works
Wong, T., Shackleton, C. H., Covey, T. R., & Ellis, G. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1830 · Cited by 159 · see citing works
Minutti, C. Z., Lacey, J. M., Magera, M. J., Hahn, S. H., McCann, M., Schulze, A., Cheillan, D., Dorche, C., Chace, D. H., Lymp, J. F., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032235 · Cited by 154 · see citing works
Teratogenic potential of corticosteroids in humans
Fraser, F. C., & Sajoo, A. (1995) · Teratology · doi:10.1002/tera.1420510107 · Cited by 153 · see citing works
Allen, D. B., Hoffman, G. L., Fitzpatrick, P., Laessig, R., Maby, S., & Slyper, A. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70321-4 · Cited by 153 · see citing works
Homma, K., Hasegawa, T., Nagai, T., Adachi, M., Horikawa, R., Fujiwara, I., Tajima, T., Takeda, R., Fukami, M., & Ogata, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2460 · Cited by 153 · see citing works
Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency.
Miller, W. L. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.8106606 · Cited by 152 · see citing works
Self-citationFractures and bone mineral density in adult women with 21-hydroxylase deficiency
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151 · see citing works
Thilén, A., Nordenström, A., Hagenfeldt, L., von Döbeln, U., Guthenberg, C., & Larsson, A. (1998) · PEDIATRICS · doi:10.1542/peds.101.4.e11 · Cited by 151 · see citing works
Wedell, A., Ritzén, E. M., Haglund-Stengler, B., & Luthman, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7232 · Cited by 150 · see citing works
Jääskeläinen, J., & Voutilainen, R. (1997) · Pediatric Research · doi:10.1203/00006450-199701000-00005 · Cited by 149 · see citing works
Cyproterone Acetate<i>Versus</i>Hydrocortisone Treatment in Late-Onset Adrenal Hyperplasia
SPRITZER, P., BILLAUD, L., THALABARD, J.-C., BIRMAN, P., MOWSZOWICZ, I., RAUX-DEMAY, M.-C., CLAIR, F., KUTTENN, F., & MAUVAIS-JARVIS, P. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-3-642 · Cited by 146 · see citing works
Deneux, C., Tardy, V., Dib, A., Mornet, E., Billaud, L., Charron, D., Morel, Y., & Kuttenn, F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.207 · Cited by 144 · see citing works
WISNIEWSKI, A. B., MIGEON, C. J., MALOUF, M. A., & GEARHART, J. P. (2004) · Journal of Urology · doi:10.1097/01.ju.0000125269.91938.f7 · Cited by 144 · see citing works
Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency.
Speiser, P. W., Serrat, J., New, M. I., & Gertner, J. M. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.6.1464643 · Cited by 143 · see citing works
Self-citationTiemensma, J., Biermasz, N. R., Middelkoop, H. A. M., van der Mast, R. C., Romijn, J. A., & Pereira, A. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0512 · Cited by 142 · see citing works
der Grinten, H. L. C., Sweep, F. C. G. J., Blickman, J. G., Hermus, A. R., & Otten, B. J. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0201 · Cited by 142 · see citing works
Girgis, R., & Winter, J. S. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4320 · Cited by 139 · see citing works
Claahsen-van der Grinten, H. L., Otten, B. J., Takahashi, S., Meuleman, E. J. H., Hulsbergen-van de Kaa, C., Sweep, F. C. G. J., & Hermus, A. R. M. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1311 · Cited by 139 · see citing works
der Grinten, H. L. C., Otten, B. J., Hermus, A. R., Sweep, F. C. G. J., & de Kaa, C. A. H. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.051 · Cited by 139 · see citing works
Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues
Ogilvie, M., Crouch, N. S., Rumsby, G., Creighton, S. M., Liao, L., & Way, G. S. C. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02410.x · Cited by 136 · see citing works
Bonfig, W., Dalla Pozza, S. B., Schmidt, H., Pagel, P., Knorr, D., & Schwarz, H. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0942 · Cited by 136 · see citing works
Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience
Premawardhana, L. D. K. E., Hughes, I. A., Read, G. F., & Scanlon, M. F. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1360962.x · Cited by 135 · see citing works
Armengaud, J.-B., Charkaluk, M.-L., Trivin, C., Tardy, V., Bréart, G., Brauner, R., & Chalumeau, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0314 · Cited by 135 · see citing works
Obesity in 21-hydroxylase deficient patients
Cornean, R. E., Hindmarsh, P. C., & Brook, C. G. D. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.78.3.261 · Cited by 135 · see citing works
Charmandari, E., Hindmarsh, P. C., Johnston, A., & Brook, C. G. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7522 · Cited by 134 · see citing works
Hoimes‐Walker, D. J., Conway, G. S., Honour, J. W., Rumsby, G., & Jacobs, H. S. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02034.x · Cited by 134 · see citing works
van der Kamp, H. J., Slijper, F. M. E., & Bullinger, M. (1996) · European Journal of Pediatrics · doi:10.1007/bf01957920 · Cited by 133 · see citing works
Resmini, E., Santos, A., Gómez-Anson, B., Vives, Y., Pires, P., Crespo, I., Portella, M. J., de Juan-Delago, M., Barahona, M.-J., & Webb, S. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2231 · Cited by 133 · see citing works
Congenital adrenal hyperplasia and P450 oxidoreductase deficiency
Krone, N., Dhir, V., Ivison, H. E., & Arlt, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02740.x · Cited by 131 · see citing works
Rivkees, S. A., & Crawford, J. D. (2000) · PEDIATRICS · doi:10.1542/peds.106.4.767 · Cited by 130 · see citing works
Peña, A. (1989) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(89)80514-7 · Cited by 129 · see citing works
Neonatal screening for congenital adrenal hyperplasia
van der Kamp, H., & Wit, J. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u071 · Cited by 128 · see citing works
Brain, C. E., Creighton, S. M., Mushtaq, I., Carmichael, P. A., Barnicoat, A., Honour, J. W., Larcher, V., & Achermann, J. C. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.01.006 · Cited by 126 · see citing works
Verma, S., VanRyzin, C., Sinaii, N., Kim, M. S., Nieman, L. K., Ravindran, S., Calis, K. A., Arlt, W., Ross, R. J., & Merke, D. P. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03636.x · Cited by 126 · see citing works
Self-citationDevelopment and Performance Evaluation of a Tandem Mass Spectrometry Assay for 4 Adrenal Steroids
Kushnir, M. M., Rockwood, A. L., Roberts, W. L., Pattison, E. G., Owen, W. E., Bunker, A. M., & Meikle, A. W. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068445 · Cited by 125 · cited 1× · see citing works
“Assays of sufficient sensitivity such as immunoassays after extraction and chromatography, or LC/MS-MS, should be used in conjunction with appropriate reference data (42, 141).”
Olgemöller, B., Roscher, A. A., Liebl, B., & Fingerhut, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021732 · Cited by 124 · see citing works
Meyer-Bahlburg, H. F. L., Dolezal, C., Baker, S. W., Carlson, A. D., Obeid, J. S., & New, M. I. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021129 · Cited by 123 · see citing works
Self-citationDickinson, H., Walker, D. W., Wintour, E. M., & Moritz, K. M. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00481.2006 · Cited by 120 · see citing works
Samarasinghe, R. A., Di Maio, R., Volonte, D., Galbiati, F., Lewis, M., Romero, G., & DeFranco, D. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102821108 · Cited by 120 · see citing works
Caulfield, M. P., Lynn, T., Gottschalk, M. E., Jones, K. L., Taylor, N. F., Malunowicz, E. M., Shackleton, C. H. L., Reitz, R. E., & Fisher, D. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8712 · Cited by 120 · see citing works
Janzen, N., Sander, S., Terhardt, M., Peter, M., & Sander, J. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.11.006 · Cited by 119 · see citing works
How safe is long-term prenatal glucocorticoid treatment?
Seckl, J. R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540370067039 · Cited by 118 · see citing works
Balsamo, A., Cacciari, E., Piazzi, S., Cassio, A., Bozza, D., Pirazzoli, P., & Zappulla, F. (1996) · PEDIATRICS · doi:10.1542/peds.98.3.362 · Cited by 116 · see citing works
Fitness, J., Dixit, N. M., WEBSTER, D. R., Torresani, T., Pergolizzi, R. G., Speiser, P., & Day, D. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5550 · Cited by 116 · see citing works
Self-citationMartinez-Aguayo, A., Rocha, A., Rojas, N., García, C., Parra, R., Lagos, M., Valdivia, L., Poggi, H., & Cattani, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0383 · Cited by 114 · see citing works
van der Kamp, H. J., Oudshoorn, C. G. M., Elvers, B. H., van Baarle, M., Otten, B. J., Wit, J. M., & Verkerk, P. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2136 · Cited by 114 · see citing works
Roche, E. F., Charmandari, E., Dattani, M. T., & Hindmarsh, P. C. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01757.x · Cited by 113 · see citing works
Lin-Su, K., Vogiatzi, M. G., Marshall, I., Harbison, M. D., Macapagal, M. C., Betensky, B., Tansil, S., & New, M. I. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2128 · Cited by 111 · see citing works
Helleday, J. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.4.933 · Cited by 111 · see citing works
Feminizing genitoplasty: state of the art
Rink, R. C., & Adams, M. C. (1998) · World Journal of Urology · doi:10.1007/s003450050055 · Cited by 110 · see citing works
(1988) · PubMed · Cited by 110 · see citing works
Self-citationAntenatal glucocorticoids and the developing brain: mechanisms of action
Matthews, S. G. (2001) · Seminars in Neonatology · doi:10.1053/siny.2001.0066 · Cited by 108 · see citing works
Stikkelbroeck, N. M. M. L., Beerendonk, C. C. M., Willemsen, W. N. P., Schreuders-Bais, C. A., Feitz, W. F. J., Rieu, P. N. M. A., Hermus, A. R., & Otten, B. J. (2003) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/s1083-3188(03)00155-4 · Cited by 107 · see citing works
Synthetic glucocorticoids: antenatal administration and long-term implications.
Sloboda, D., Challis, J., Moss, T., & Newnham, J. (2005) · Current pharmaceutical design · doi:10.2174/1381612053507873 · Cited by 106 · see citing works
Speiser, P., Agdere, L., Ueshiba, H., White, P. C., & New, M. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240302 · Cited by 106 · see citing works
Self-citationCurrent status of neonatal screening for congenital adrenal hyperplasia
Pang, S., & Shook, M. K. (1997) · Current Opinion in Pediatrics · doi:10.1097/00008480-199708000-00018 · Cited by 104 · see citing works
Quintos, J. B., Vogiatzi, M. G., Harbison, M. D., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7412 · Cited by 104 · see citing works
Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients
Van der Kamp, H. J. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.87.2.139 · Cited by 104 · see citing works
Psychological adjustment in children and adults with congenital adrenal hyperplasia
Berenbaum, S. A., Bryk, K. L. K., Duck, S. C., & Resnick, S. M. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.03.037 · Cited by 103 · see citing works
Nermoen, I., Rørvik, J., Holmedal, S. H., Hykkerud, D. L., Fougner, K. J., Svartberg, J., Husebye, E. S., & Løvås, K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04151.x · Cited by 103 · see citing works
How Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia?
Grosse, S. D., & Van Vliet, G. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098400 · Cited by 102 · see citing works
Balsamo, A., Cicognani, A., Baldazzi, L., Barbaro, M., Baronio, F., Gennari, M., Bal, M., Cassio, A., Kontaxaki, K., & Cacciari, E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030123 · Cited by 102 · see citing works
Mercè Fernández‐Balsells, M., Muthusamy, K., Smushkin, G., Lampropulos, J. F., Elamin, M. B., Abu Elnour, N. O., Elamin, K. B., Agrwal, N., Gallegos‐Orozco, J. F., Lane, M. A., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03826.x · Cited by 101 · see citing works
Hirvikoski, T., Nordenström, A., Lindholm, T., Lindblad, F., Ritzén, E. M., & Lajić, S. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0280 · Cited by 101 · see citing works
Manoli, I., Kanaka-Gantenbein, C., Voutetakis, A., Maniati-Christidi, M., & Dacou‐Voutetakis, C. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01645.x · Cited by 100 · see citing works
Sexual function and attitudes toward surgery after feminizing genitoplasty
Fagerholm, R., Santtila, P., Miettinen, P. J., Mattila, A., Rintala, R., & Taskinen, S. (2011) · Journal of Urology · doi:10.1016/j.juro.2010.12.099 · Cited by 99 · see citing works
Merza, Z., Rostami‐Hodjegan, A., Memmott, A., Doane, A., Ibbotson, V., Newell‐Price, J., Tucker, G. T., & Ross, R. J. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02544.x · Cited by 98 · see citing works
Schwarz, E., Liu, A., Randall, H., Haslip, C., Keune, F., Murray, M., Longo, N., & Pasquali, M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181aa3777 · Cited by 97 · see citing works
Liao, L., Doyle, J., Crouch, N. S., & Creighton, S. M. (2006) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610500443527 · Cited by 97 · see citing works
Drake, A. J., Raubenheimer, P. J., Kerrigan, D., McInnes, K. J., Seckl, J. R., & Walker, B. R. (2010) · Endocrinology · doi:10.1210/en.2009-1088 · Cited by 97 · see citing works
Martinerie, L., Viengchareun, S., Delezoide, A.-L., Jaubert, F., Sinico, M., Prevot, S., Boileau, P., Meduri, G., & Lombès, M. (2009) · Endocrinology · doi:10.1210/en.2008-1498 · Cited by 97 · see citing works
Prenatal Treatment of Congenital Adrenal Hyperplasia
Forest, M. G., Morel, Y., & David, M. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00067-8 · Cited by 95 · see citing works
Effects into adulthood of single or repeated antenatal corticosteroids in sheep
Moss, T. J. M., Doherty, D. A., Nitsos, I., Sloboda, D. M., Harding, R., & Newnham, J. P. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.065 · Cited by 95 · see citing works
Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency
Punthakee, Z., Legault, L., & Polychronakos, C. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00294-4 · Cited by 95 · see citing works
Bone density in young patients with congenital adrenal hyperplasia
Mora, S., Saggion, F., Russo, G., Weber, G., Bellini, A., Prinster, C., & Chiumello, G. (1996) · Bone · doi:10.1016/8756-3282(96)00003-8 · Cited by 95 · see citing works
MEDICAL TREATMENT OF INTERSEX: PARENTAL PERSPECTIVES
DAYNER, J. E., LEE, P. A., & HOUK, C. P. (2004) · Journal of Urology · doi:10.1097/01.ju.0000138519.12573.3a · Cited by 94 · see citing works
Outcome of congenital adrenal hyperplasia
Kuhnle, U., & Bullinger, M. (1997) · Pediatric Surgery International · doi:10.1007/bf01258714 · Cited by 92 · see citing works
Effect of newborn screening for congenital adrenal hyperplasia
Brosnan, P. G., Brosnan, C. A., Kemp, S. F., Domek, D. B., Jelley, D. H., Blackett, P. R., & Riley, W. J. (1999) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.153.12.1272 · Cited by 91 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Coleman, E., Bockting, W. O., Botzer, M., Cohen‐Kettenis, P. T., Cuypere, G. D., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., et al. (2012) · International Journal of Transgenderism · doi:10.1080/15532739.2011.700873 · Cited by 3,145 · see citing works
Self-citationThe Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113 · see citing works
Self-citationStandards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M. G., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,843 · see citing works
Self-citationThe Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · see citing works
Self-citationLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919 · see citing works
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769 · see citing works
“a 17-OHprogesterone 1000 ng/dL is diagnostic for 21-OH deficiency (14).”
BackgroundMethodInfluentialSelf-citationSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234 · see citing works
Self-citationCongenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669 · see citing works
Self-citationCongenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556 · see citing works
Self-citationHuman cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505 · see citing works
Self-citationMartin, K. A., Chang, R. J., Ehrmann, D. A., Ibáñez, L., Løbo, R. A., Rosenfield, R. L., Shapiro, J., Montori, V. M., & Swiglo, B. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2437 · Cited by 506 · see citing works
Self-citationCaring for individuals with a difference of sex development (DSD): a Consensus Statement
Cools, M., Nordenström, A., Robeva, R. N., Hall, J., Westerveld, P., Flück, C. E., Köhler, B., Berra, M., Springer, A., Schweizer, K., et al. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0010-8 · Cited by 467 · see citing works
Sheng, J. A., Bales, N. J., Myers, S. A., Bautista, A. I., Roueinfar, M., Hale, T. M., & Handa, R. J. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.601939 · Cited by 418 · see citing works
Martin, K. A., Anderson, R. R., Chang, R. J., Ehrmann, D. A., Lobo, R. A., Murad, M. H., Pugeat, M. M., & Rosenfield, R. L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00241 · Cited by 339 · see citing works
New, M. I., Tong, Y. K., Yuen, T., Jiang, P., Pina, C., Chan, K. C. A., Khattab, A., Liao, G. J. W., Yau, M., Kim, S.-M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1118 · Cited by 319 · see citing works
“E1028 New et al Noninvasive CAH Diagnosis Using Maternal Plasma DNA J Clin Endocrinol Metab, June 2014, 99(6):E1022–E1030”
MethodInfluentialClinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313 · see citing works
Self-citationGenetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312 · see citing works
Adolescent polycystic ovary syndrome according to the international evidence-based guideline
Peña, A. S., Witchel, S. F., Hoeger, K. M., Oberfield, S. E., Vogiatzi, M. G., Misso, M. L., Garad, R. M., Dabadghao, P., & Teede, H. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01516-x · Cited by 331 · see citing works
Self-citationSurgery in disorders of sex development (DSD) with a gender issue: If (why), when, and how?
Mouriquand, P. D. E., Gorduza, D. B., Gay, C.-L., Meyer‐Bahlburg, H. F. L., Baker, L. A., Baskin, L. S., Bouvattier, C. M., Braga, L. H., Caldamone, A. C., Duranteau, L., et al. (2016) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2016.04.001 · Cited by 248 · see citing works
“Keeping the genital tubercle intact is recommended if it is not too big (<2 cm) [26], although enhanced clitoris is a common cause of consultation in CAH girls with untouched clitoris.”
BackgroundMethodSelf-citationFlück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248 · see citing works
Self-citationGuideline panels should seldom make good practice statements: guidance from the GRADE Working Group
Guyatt, G. H., Alonso‐Coello, P., Schünemann, H. J., Djulbegović, B., Nothacker, M., Lange, S., Murad, M. H., & Akl, E. A. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.07.006 · Cited by 245 · see citing works
“For patients with congenital adrenal hyperplasia, we recommend monitoring patients for signs of glucocorticoid excess [8].”
BackgroundTurcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231 · see citing works
Self-citationHUNTER, S. K., S. ANGADI, S., BHARGAVA, A., HARPER, J., HIRSCHBERG, A. L., D. LEVINE, B., L. MOREAU, K., J. NOKOFF, N., STACHENFELD, N. S., & BERMON, S. (2023) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003300 · Cited by 241 · see citing works
Report of the American Psychiatric Association Task Force on Treatment of Gender Identity Disorder
Byne, W. M., Bradley, S. J., Coleman, E., Eyler, A. E., Green, R. R., Menvielle, E. J., Meyer‐Bahlburg, H. F. L., Pleak, R. R., & Tompkins, D. A. (2012) · Archives of Sexual Behavior · doi:10.1007/s10508-012-9975-x · Cited by 221 · see citing works
“…of, and need for, mental-health service providers with expertise in providing services to individuals with gender dysphoria, GID and DSDs (Consortium on the Management of Disorders of Sex Development, 2006a; Hembree et al., 2009; Hughes et al., 2006; MeyerBahlburg, 2008; Speiser et al., 2010).”
BackgroundSelf-citationTreating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad ?
Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 225 · see citing works
“Conversely, supraphysiological (and still occasionally reverse-circadian) doses are often needed to control patients with CAH.”
BackgroundInfluentialFalhammar, H., Frisén, L., Hirschberg, A. L., Norrby, C., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2093 · Cited by 204 · see citing works
Guideline panels should not GRADE good practice statements
Guyatt, G. H., Schünemann, H. J., Djulbegović, B., & Akl, E. A. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.011 · Cited by 210 · see citing works
“For patients with congenital adrenal hyperplasia, we recommend monitoring patients for signs of glucocorticoid excess [5].”
BackgroundCarmina, E., Dewailly, D., Escobar-Morreale, H. F., Keleştimur, F., Morán, C., Oberfield, S. E., Witchel, S. F., & Azziz, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx014 · Cited by 201 · see citing works
“Overall, while some NCAH patients may be at risk for short stature, this risk appears to be relatively small and most children reach a relatively normal final height for family standards (Speiser et al., 2010) (Level of evidence: B).”
Self-citationIncreased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Falhammar, H., Frisén, L., Norrby, C., Hirschberg, A. L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2957 · Cited by 196 · see citing works
“An increased femaleto-male ratio in the most severely affected in the UK (34), and in CAH populations in general have been interpreted as evidence of this (2).”
BackgroundKamrath, C., Hochberg, Z., Hartmann, M. F., Remer, T., & Wudy, S. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1997 · Cited by 191 · see citing works
“It has been speculated that the backdoor pathway could be involved in androgen synthesis in patients with 21-OHD (4, 10, 11); however, no data have yet been published supporting this hypothesis.”
BackgroundEndocrine disorders & female infertility
Unuane, D., Tournaye, H. J., Velkeniers, B., & Poppe, K. G. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.08.001 · Cited by 187 · see citing works
Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 187 · see citing works
Adult Height in Patients with Congenital Adrenal Hyperplasia: A Systematic Review and Metaanalysis
Muthusamy, K., Elamin, M. B., Smushkin, G., Murad, M. H., Lampropulos, J. F., Elamin, K. B., Abu Elnour, N. O., Gallegos-Orozco, J. F., Fatourechi, M. M., Agrwal, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2616 · Cited by 182 · see citing works
Self-citationMazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181 · see citing works
Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177 · see citing works
“If elected, treatment from an experienced team in research centers that monitor outcomes is recommended.(29)”
BackgroundInfluentialDevelopment of adrenal cortex zonation
Xing, Y., Lerario, A. M., Rainey, W., & Hammer, G. D. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.001 · Cited by 174 · see citing works
“The most common form of CAH is the 21-hydroxylase deficiency (CYP21A2), accounting for more than 95% of cases.(150) More than 100 mutations have been described in this disease and a strong genotype-phenotype correlation is observed.”
Mallappa, A., Sinaii, N., Kumar, P., Whitaker, M. J., Daley, L.-A., Digweed, D., Eckland, D. J. A., Van Ryzin, C., Nieman, L. K., Arlt, W., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3809 · Cited by 167 · see citing works
“recommended therapy in growing children (2).”
Self-citationEngels, M., Span, P. N., van Herwaarden, A. E., Sweep, F. C. G. J., Stikkelbroeck, N. M. M. L., & Claahsen-van der Grinten, H. L. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00258 · Cited by 163 · see citing works
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158 · see citing works
Normal and Premature Adrenarche
Rosenfield, R. L. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab009 · Cited by 163 · see citing works
Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 147 · see citing works
Self-citationClinical guidelines for the management of adrenal incidentaloma
Lee, J.-M., Kim, M. K., Ko, S.-H., Koh, J.-M., Kim, B.-Y., Kim, S. W., Kim, S.-K., Kim, H. J., Ryu, O.-H., Park, J., et al. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.200 · Cited by 147 · see citing works
Raff, H., Sharma, S. T., & Nieman, L. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130035 · Cited by 141 · see citing works
Hannah-Shmouni, F., Morissette, R., Sinaii, N., Elman, M., Prezant, T. R., Chen, W., Pulver, A., & Merke, D. P. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.46 · Cited by 141 · see citing works
Self-citationClinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Bulsari, K., & Falhammar, H. (2016) · Endocrine · doi:10.1007/s12020-016-1189-x · Cited by 139 · see citing works
Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency
Reisch, N., Willige, M., Kohn, D., Schwarz, H.-P., Allolio, B., Reincke, M., Quinkler, M., Hahner, S., & Beuschlein, F. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0161 · Cited by 136 · see citing works
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 138 · see citing works
Self-citationManagement of adolescents with congenital adrenal hyperplasia
Merke, D. P., & Poppas, D. P. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70138-4 · Cited by 134 · see citing works
Self-citationFalhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127 · see citing works
Almasri, J., Zaiem, F., Rodriguez-Gutierrez, R., Tamhane, S. U., Iqbal, A. M., Prokop, L. J., Speiser, P. W., Baskin, L. S., Bancos, I., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01863 · Cited by 127 · see citing works
“Classic CAH is an autosomal recessive transmitted disorder due to a mutation in the CYP21A2 gene (90% to 95% of cases), which transcribes 21-hydroxylase, with a consequent defective conversion of 17-hydroxyprogesterone to 11-deoxycortisol (2, 3).”
BackgroundSelf-citationScreening for Endocrine Hypertension: An Endocrine Society Scientific Statement
Young, W. F., Calhoun, D. A., Lenders, J. W. M., Stowasser, M., & Textor, S. C. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00054 · Cited by 126 · see citing works
Tamhane, S., Rodriguez-Gutierrez, R., Iqbal, A. M., Prokop, L. J., Bancos, I., Speiser, P. W., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01862 · Cited by 123 · see citing works
Self-citationApproach to the patient: the adult with congenital adrenal hyperplasia
Auchus, R. J., & Arlt, W. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1440 · Cited by 121 · see citing works
“Dexamethasone use for prenatal treatment of affected fetuses with 21OHD has been employed but is considered experimental for these reasons (28).”
Bouvattier, C., Esterle, L., Renoult-Pierre, P., de la Perrière, A. B., Illouz, F., Kerlan, V., Pascal-Vigneron, V., Drui, D., Christin-Maitre, S., Galland, F., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4124 · Cited by 116 · see citing works
“Congenitaladrenalhyperplasiadueto21OHD does not therefore seem to affect men’s intimate relationships, whereas sexuality is severely affected in women with this disease, who are markedly less likely to live with a partner (1, 3, 6, 7, 9).”
BackgroundDevelopment of the human penis and clitoris
Baskin, L. S., Shen, J., Sinclair, A. W., Cao, M., Liu, X., Liu, G., Isaacson, D. S., Overland, M. R., Li, Y., & Cunha, G. R. (2018) · Differentiation · doi:10.1016/j.diff.2018.08.001 · Cited by 117 · see citing works
“Based on clinical observations, genetic females with congenital adrenal hyperplasia can form a normal appearing penis consistent with androgen receptor expression in both the male and female developing human genital tubercle (Speiser et al., 2010; Baskin, 2017b).”
BackgroundSelf-citationPsychological Aspects of the Treatment of Patients with Disorders of Sex Development
Gardner, M., Cohen‐Kettenis, P. T., & Sandberg, D. E. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1324729 · Cited by 114 · see citing works
Baumgartner-Parzer, S., Witsch-Baumgartner, M., & Hoeppner, W. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0653-5 · Cited by 110 · see citing works
Timing and nature of reconstructive surgery for disorders of sex development – Introduction
Creighton, S. M., Chernausek, S. D., Romao, R. L. P., Ransley, P. G., & Salle, J. P. (2012) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2012.10.001 · Cited by 114 · see citing works
Disorders of sex development: effect of molecular diagnostics
Achermann, J. C., Domenice, S., Bachega, T. A. S. S., Nishi, M. Y., & Mendonca, B. B. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.69 · Cited by 108 · see citing works
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113 · see citing works
Self-citationStrandqvist, A., Falhammar, H., Lichtenstein, P., Hirschberg, A. L., Wedell, A., Norrby, C., Nordenskjöld, A., Frisén, L., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3326 · Cited by 111 · see citing works
Kulle, A., Krone, N., Holterhus, P. M., Schuler, G., Greaves, R. F., Juul, A., de Rijke, Y. B., Hartmann, M. F., Saba, A., Hiort, O., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0953 · Cited by 111 · see citing works
Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer
Auchus, R. J., Yu, M. K., Nguyen, S., & Mundle, S. D. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0167 · Cited by 111 · see citing works
Turcu, A. F., Mallappa, A., Elman, M. S., Avila, N. A., Marko, J., Rao, H., Tsodikov, A., Auchus, R. J., & Merke, D. P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3989 · Cited by 107 · see citing works
Self-citationHealth Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Reisch, N., Arlt, W., & Krone, N. P. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327794 · Cited by 107 · see citing works
MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
Markopoulos, M. C., Kassi, E., Alexandraki, K., Mastorakos, G. P., & Kaltsas, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0468 · Cited by 106 · see citing works
Yanase, T., Tajima, T., Katabami, T., Iwasaki, Y., Tanahashi, Y., Sugawara, A., Hasegawa, T., Mune, T., Oki, Y., Nakagawa, Y., et al. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0242 · Cited by 108 · see citing works
Fertility in patients with congenital adrenal hyperplasia
Reichman, D. E., White, P. C., New, M. I., & Rosenwaks, Z. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.002 · Cited by 104 · see citing works
Self-citationNermoen, I., Rørvik, J., Holmedal, S. H., Hykkerud, D. L., Fougner, K. J., Svartberg, J., Husebye, E. S., & Løvås, K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04151.x · Cited by 103 · see citing works
Treatment and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Walker, B. R., Arlt, W., & Ross, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.239 · Cited by 102 · see citing works
Fisher, A. D., Ristori, J., Fanni, E., Castellini, G., Forti, G., & Maggi, M. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0482-0 · Cited by 100 · see citing works
“%) of 46,XX patients with CAH raised as females develop a female gender identity later on [24].”
BackgroundInfluentialEvidence regarding cosmetic and medically unnecessary surgery on infants
Diamond, M., & Garland, J. (2013) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2013.10.021 · Cited by 103 · see citing works
Towards improved genetic diagnosis of human differences of sex development
Délot, E. C., & Vilain, E. J. N. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00365-5 · Cited by 100 · see citing works
NonClassic Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/625105 · Cited by 132 · see citing works
Self-citationTardy-Guidollet, V., Menassa, R., Costa, J.-M., David, M., Bouvattier-Morel, C., Baumann, C., Houang, M., Lorenzini, F., Philip, N., Odent, S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2895 · Cited by 96 · see citing works
Parental Reports of Stigma Associated with Child’s Disorder of Sex Development
Rolston, A. M., Gardner, M., Vilain, E. J. N., & Sandberg, D. E. (2015) · International Journal of Endocrinology · doi:10.1155/2015/980121 · Cited by 100 · see citing works
Sandberg, D. E., Gardner, M., Callens, N., Mazur, T., & the DSD‐TRN Psychosocial Workgroup, T. D. A. A. N. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31561 · Cited by 99 · see citing works
“In the case of CAH, the interval between visits (commonly 3 months; [Speiser et al., 2010]) provides ample opportunity to embed a psychosocial component into the model of care.”
BackgroundSteroid 21-hydroxylase deficiency in congenital adrenal hyperplasia
Parsa, A. A., & New, M. I. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.06.015 · Cited by 100 · see citing works
Falhammar, H., Butwicka, A., Landén, M., Lichtenstein, P., Nordenskjöld, A., Nordenström, A., & Frisén, L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3707 · Cited by 98 · see citing works
Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency
Auchus, R. J., Buschur, E. O., Chang, A. Y., Hammer, G. D., Ramm, C., Madrigal, D., Wang, G., Gonzalez, M., Xu, X. S., Smit, J. W., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1258 · Cited by 97 · see citing works
Clinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106 · see citing works
Genetics of Congenital Adrenal Hyperplasia
Hannah-Shmouni, F., Chen, W., & Merke, D. P. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.008 · Cited by 97 · see citing works
Self-citationMazziotti, G., Formenti, A. M., Frara, S., Roca, E., Mortini, P., Berruti, A., & Giustina, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0154 · Cited by 96 · see citing works
El-Maouche, D., Hargreaves, C. J., Sinaii, N., Mallappa, A., Veeraraghavan, P., & Merke, D. P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00208 · Cited by 93 · see citing works
Self-citationCongenital adrenal hyperplasia: time to replace 17OHP with 21-deoxycortisol
Miller, W. L. (2019) · Hormone Research in Paediatrics · doi:10.1159/000501396 · Cited by 93 · see citing works
Self-citationLivadas, S., Dracopoulou, M., Dastamani, A., Sertedaki, A., Maniati-Christidi, M., Magiakou, A.-M., Kanaka‐Gantenbein, C., Chrousos, G. P., & Dacou‐Voutetakis, C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12543 · Cited by 90 · see citing works
Nella, A. A., Mallappa, A., Perritt, A. F., Gounden, V., Kumar, P., Sinaii, N., Daley, L.-A., Ling, A., Liu, C.-Y., Soldin, S. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1916 · Cited by 91 · see citing works
“(1) Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA 20892; (2) National Institutes of Health Clinical Center, Bethesda MD, USA 20892”
BackgroundSelf-citationModified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Merke, D. P., Mallappa, A., Arlt, W., Brac de la Perriere, A., Lindén Hirschberg, A., Juul, A., Newell-Price, J., Perry, C. G., Prete, A., Rees, D. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab051 · Cited by 109 · see citing works
Self-citationWhittle, E., & Falhammar, H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00136 · Cited by 87 · see citing works
Short‐ and long‐term effects of exposure to natural and synthetic glucocorticoids during development
Singh, R. R., Cuffe, J. S. M., & Moritz, K. M. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12009 · Cited by 88 · see citing works
Comprehensive analysis of congenital adrenal hyperplasia using long-read sequencing
Liu, Y., Chen, M., Liu, J., Mao, A., Teng, Y., Yan, H., Zhu, H., Li, Z., Liang, D., & Wu, L. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac046 · Cited by 80 · see citing works
Bonfig, W., Roehl, F.-W., Riedl, S., Dörr, H. G., Bettendorf, M., Brämswig, J., Schönau, E., Riepe, F., Hauffa, B., Holl, R. W., et al. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpv087 · Cited by 84 · see citing works
Approach to androgen excess in women: Clinical and biochemical insights
Cussen, L., McDonnell, T., Bennett, G., Thompson, C. J., Sherlock, M., & O’Reilly, M. (2022) · Clinical Endocrinology · doi:10.1111/cen.14710 · Cited by 92 · see citing works
“The Endocrine Society Guidelines recommend a stimulated 17OHP cut‐off value of 30 nmol/L for NCCAH diagnosis.(72)”
MethodReisch, N., Rottenkolber, M., Greifenstein, A., Krone, N., Schmidt, H., Reincke, M., Schwarz, H.-P., & Beuschlein, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3181 · Cited by 82 · see citing works
“Steroid 21-hydroxylase deficiency (21-OHD) accounts for more than 95% of CAH cases (1).”
MethodInfluentialBone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia
Falhammar, H., Filipsson Nyström, H., Wedell, A., Brismar, K., & Thorén, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0865 · Cited by 82 · see citing works
Merke, D. P., Chen, W., Morissette, R., Xu, Z., Van Ryzin, C., Sachdev, V., Hannoush, H., Shanbhag, S. M., Acevedo, A. T., Nishitani, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3148 · Cited by 82 · see citing works
Self-citationNandagopal, R., Sinaii, N., Avila, N. A., Van Ryzin, C., Chen, W., Finkielstain, G. P., Mehta, S. P., McDonnell, N. B., & Merke, D. P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0019 · Cited by 81 · see citing works
Self-citationHow should postmenopausal androgen excess be evaluated?
Rothman, M. S., & Wierman, M. E. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04040.x · Cited by 81 · see citing works
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
Trapp, C. M., & Oberfield, S. E. (2011) · Steroids · doi:10.1016/j.steroids.2011.12.009 · Cited by 81 · see citing works
Self-citationRepping-Wuts, H. J. W. J., Stikkelbroeck, N. M. M. L., Noordzij, A., Kerstens, M., & Hermus, A. R. M. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1094 · Cited by 80 · see citing works
- Authors
- Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., Ritzen, M., & White, P. C.
- Affiliations
- Hofstra University (US)
- Cedars-Sinai Medical Center (US)
- National Institutes of Health (US)
- Columbia University (US)
- Mayo Clinic (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-09
- Volume
- 95
- Issue
- 9
- Pages
- 4133-4160
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2936060
- OpenAlex
- W1972087695
- Cited by
- 1,484
- References
- 342
- Citations by year
- 2026: 18 · 2025: 41 · 2024: 96 · 2023: 103 · 2022: 130 · 2021: 130 · 2020: 98 · 2019: 123 · 2018: 118 · 2017: 97 · 2016: 105 · 2015: 85 · 2014: 87 · 2013: 83 · 2012: 71
- FWCI
- 26.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion)
- PubMed Central (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, newborn screening, fetal therapy, glucocorticoid therapy, iatrogenic Cushing's syndrome, mineralocorticoids, sodium supplementation
- MeSH terms
- Adrenal Hyperplasia, Congenital, Algorithms, Female, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-14.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-14.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review